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Superoxide dismutase and renin gene expression after experimental
acute ischemic renal injury. H.K Kim, J.R. Koo, TS. Chung, DR. C/ia, and
WY Cho, Department of Internal Medicine, College of Medicine, Korea
University, Seoul, Korea. To investigate the expression of antioxidant
superoxide dismutase (SOD) and renin genes during acute ischemic renal
injury, Northern blot and hybridization of renal tissue at different reper-
fusion time in the ischemic ARF were performed. In this experiment, 21
rats were divided into 3 groups: Group I (N = 3) was a control group,
Group II (N = 3) was a sham operation group with bilateral flank incision
and decapsulation of the kidneys. Group HI (N = 15) was an ischemic
model with right nephrectomy followed by left renal artery clamping for 40
minutes. In the ischemic renal injury group, the rats were subdivided into
3 groups according to the reperfusion time, such as 1, 24, and 72 hours
(Groups lila, Ilib, Tile). SOD gene expression was made markedly
decreased by renal ischemia and showed persistently decreased pattern
during reperfusion period. The expression of renin gene was markedly
decreased after 1 hour of reflow and progressively increased to one-half of
the control level 72 hours after reperfusion. In conclusion, SOD gene
expression was rapidly decreased after ischemia and this antioxidant
enzyme probably does not act as a protective mechanism of acute ischemic
renal failure. The expression pattern of the renin gene suggests that renin
gene is not expressed as a direct mediator of acute ischemic renal injury
but probably has some roles in the recovery phase of ARF.
The clinical aspect of the hemolyic uremic syndrome. H. W. Park, IS.
Ha, HI. Cheong, and Y Choi, Department of Pediatrics, College of
Medicine, Seoul National University, Seoul, Korea. To investigate the
clinical characteristics and to find factors which have adverse effects on the
outcome, we reviewed the medical records of children seen at our hospital
between 1981 and 1995 with a discharge diagnosis of hemolytic uremic
syndrome. A total of nineteen patients (11 girls, 7 boys) were identified.
The age at presentation varied from 1 month to 10 years, with a median of
1.71 years. Twelve (66.7%) of the children had a diarrheal prodrome and
6 (33.3%) had grossly bloody stool. Oligoanuria developed in fourteen
(77.8%) and gross hematuria in 9 (50.0%). Eight (44.4%) children had
seizures and alteration of consciousness occurred in 6 (3.36%). One child
had a sibling who died of hemolytic uremic syndrome. In 9 children
(50.0%) a serum uric acid level greater than 15 mg/dl was observed. Stools
were cultured for Salmonella and Shigella but none was identified with the
bacteria. Analysis for verotoxin production was not identified. Overall
outcome is poor. Of the 18 children, 8 (44.4%) recovered their renal
function completely. Hypertension with proteinuria or microscopic hema-
tuna persisted after recovery from renal failure in 3 (16.7%). Four
(22.2%) progressed to end-stage renal disease requiring dialysis and 2
(11.1%) slowly developed renal insufficiency. One (5.6%) died of acute
renal failure. The mean polymorphonuclear leukocyte (PMN) count was
significantly higher in the 7 patients who developed chronic renal impair-
ment or died during acute phase than in the 11 patients who recovered
normal glomerular filtration rate (P < 0.01). We conclude that a high
PMN count at presentation indicates a poor prognosis.
Hemolytic uremic syndrome in adults. S.f. Lee, H.J. Chin, YS. Cho, Hf.
Yoon, C. A/in, J.S. Han, S. Kim, J.S. Lee, Department of Internal Medicine,
Seoul National University College of Medicine, Seoul, Korea. Hemolytic
uremic syndrome (HUS), characterized by microangiopathic hemolytic
anemia, thrombocytopenia and renal insufficiency, is a rare disease in
adults with various causes and poor prognosis; however, the clinical
features of adult HUS are not well-known in Korea, and we evaluated the
12 patients diagnosed with HUS in the Seoul National University Hospital
from 1987 to 1994 retrospectively to analyze the clinical feature and
prognosis. There were 6 women and 6 men patients. The age was 32 years
(18—62, median, range). At admission, 4 patients had urinary symptoms
(hematuria, oliguria) and generalized edema, 3 patients urinary symptoms
and gastrointestinal symptoms (diarrhea, vomiting, abdominal pain), 2
patients urinary symptoms and neurological symptoms (hemiparesis,
convulsion), 1 patient fever and urinary symptoms, while 2 patients
without specific symptoms had laboratory abnormalities only. Drugs(mitomycin, cyclosporin, phenylpropanolamine) were the most common
cause (5 patients), followed by infectious diarrhea (2 patients), and
pregnancy (1 patient). In 3 patients, we could not find the cause. Peak
value of serum creatinine was 6.0 mg/dl (1.9—24.1 mg/dl), the lowest value
of hemoglobin was 6.1 g/dl (2.7—8.5 g/dl), the lowest value of platelet was
53,000/mm3 (6,000—108,000). Among the renal biopsies obtained from 7
patients, 3 showed severe arterial intimal thickening. Of the three patients,
two progressed to the end stage renal disease and one recurred later. Four
patients with less severe arterial lesions recovered their renal function.
During the follow up periods (2 weeks—4 years), 7 patients completely
recovered their renal function, while 5 patients did not. Of the 5 patients,
3 patients progressed to end-stage renal disease, whose peak serum
creatinine levels were significantly higher than the others. In summary, 12
adult patients of HUS were mainly presented with urologic symptoms, and
drugs were the most common cause. In patients who progressed to the
end-stage renal disease, the peak level of serum creatinine was signifi-
cantly higher than in the others.
Acute renal failure in the elderly. W.S. Huh, U.S. leon, YS. Cho, YS.
Kim, H-f. Yoon, C. Ahn, J.S. Han, S. Kim, J.S. Lee, Department of Internal
Medicine, Seoul National University College of Medicine, Boramae City
Hospital, Seoul, Korea. Between January 1990, and December 1994, 105
elderly patients (over the age of sixty) were referred to the Nephrology
Division at Seoul National University Hospital as acute renal failure
(ARF; serum creatinine> 1.7 mgldl, patients who had been diagnosed to
have acute chronic renal failure were excluded). To find out about the
characteristics of ARF in the elderly, we decided to make a retrospective
study of our data. Sufficient data for analysis were available in 101 of these.
Among this group, prerenal failure occurred in 8% of the cases, ischemic
acute tubular necrosis (ATN) 31%, toxic ATN 10%, renovascular obstruc-
tion 5%, glonierular disease 5%, postrenal failure 15%, others 26%.
Ischemic ATN account for 31% of all cases of ARF in the elderly. This was
higher rate than the 18% reported in all ARF population (P < 0.05).
Dialysis was required in 31 patients (31%). Twenty-four patients were
treated by hemodialysis, 1 patient by the peritoneal route, and the other 6
patients were treated by CAVH. The most common indication was
hypervolemia (77%). Twenty-seven patients died during the period of
acute renal failure. The most common cause of death was infection (15
patients), and the others died of underlying diseases, pulmonary compli-
cations, cardiovascular complications. Among the living patients, com-
plete recovery (Cr < 1.5 mgldl) rate was 72%. Among 86 patients who
were diagnosed to have prerenal or intrinsic ARF, 25 patients died and
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mortality rate of oliguric ARF was 43% (19/44 patients). Oliguric ARF
was poor prognostic factor (P < 0.05). There were significant differences
between the living and dead groups by the APACHE II score (P < 0.05).
However, there were no significant differences in APS points and age
points. Only chronic health points made significant differences between
the living and death groups (P < 0.05). We conclude that ischemic ATN
is a more common cause of ARF in the elderly than in younger patient,
and oliguric ARF and chronic disease are poor prognostic factors.
Prognostic factors of childhood acute renal failure (ARE). C.K. fang,
I.H. Lee, S.H. Cha and B.S. ('ho, Department of Pediatrics, College of
Medicine, Kyung Hee University, Seoul, Korea. To investigate the prognostic
factors in childhood acute renal failure, we reviewed the medical records
of 59 patients with ARF who had been admitted to Kyung Hee Medical
Center between January 1990 and December 1994. The inclusion criteria
of ARF were as follows: (1) serum creatinine level> I mg/dl; (2) FEN >
3 in neonates and (3) both (1) and (2) > 1 in after the neonatal period. Of
the 59 patients, 36 were male and 23 were female. Twenty five cases were
developed during neonatal period. The etiologic factors were neonatal
respiratory distress syndrome, sepsis and neonatal asphyxia in the order of
frequency in the neonatal period. Mortality rates between oliguric and
non-oliguric ARF were similar in the neonatal period; however, oliguric
ARF showed higher mortality after the neonatal period. Patients with
hyperkalemia, hypernatremia and high negative base excess showed
higher mortality. In conclusion, most cases of childhood ARE are devel-
oped during neonatal period, and more vigorous and active approaches
are mandatory.
Acute renal failure in children. S.C. Chung, M.J. Kwon, iS. Lee, and
P. -K Kim, Department of Pediatrics, Yonsei University College of Medicine,
Seoul, Korea. A clinical study on 298 children with acute renal failure, who
had been admitted to the Department of Pediatrics, Yonsei University
Severance hospital between April 1984 and March 1994, revealed the
following results. Among the patients, 78.2% (233 cases) had prerenal
causes, renal causes in 15.8% (47 eases), postrenal cause in 0.3% (1 case).
The overall recovery rate was 42.3%, mortality rate was 34.9% and 22.8%
of patients were not improved due to discontinuing treatment against the
physician's advice. The mortality rate in neonatl period was 42.9%, the
highest among all age groups. The common causes of acute renal failure
in all age groups were sepsis and DIC, and the most common cause in
neonal period was respiratory distress syndrome. In infancy, congenital
heart disease and heart failure were the most common causes, while in
older children renal causes were higher. Peritoneal dialyses were under-
gone in 60 case (20.2%) and the recovery rate was 56.7%, while the
recovery rate of conservative treatment group was 39.2%. If socioeco-
nomic condition allows and the number of patients discontinuing treat-
ment against their physician's advice decreases, then we might anticipate
better treatment outcomes.
Correlation between nutritional status and urea kinetic modeling in
hemodialysis patients. M.K. Song, SW. Lee, SW. Kong, K.H. Choi, H.Y.
Lee, D.S. Han, J.H. Lee, and M.K C/so, Department of Internal Medicine,
College of Medicine, Department of Food and Nutrition, College of Human
Ecology, Yonsei University, Seoul, Korea. To investigate the relationship
between nutritional status and dialysis adequacy, nutritional status was
assessed by subjective global assessment (SGA) and dietary food intake by
the 24-hour recall method as well as by anthropometric measurement in 82
stable hemodialysis patients. Individual nutritional status was compared
with various biochemical and urea kinetic variables such as normalized
protein catabolic rate (NPCR), Kt/V and standardized creatinine clear-
ance (Sr). There were 57 men and 25 women with a mean hemodialysis
duration of 30.5 months; the most common causative disease was chronic
glomerulonephritis (57.2%). The mean concentration of albumin was 4.3
0.4g/dl. NPCR 1.04 0.24g/kg/day, delivered Kt/Vr, 1.30 0.31 and
Scr 66.56 10.69 l/week/1.73 m2. Thirteen patients (15.9%) were
classified as malnourished by SGA. Malnourished patients had signifi-
cantly longer hemodialysis duration (27.0 vs. 48.9 months) and lower
values in blood urea nitrogen concentration (80.4 18.0 vs. 59.5 19.1
mg/dl), RRF (residual renal function, 1.21 vs. 0.31 mI/mm), NPCR (1.09
0.22 vs. 0.77 0.14 glkg/day) and Kt/V,,rea (1.33 0.31 vs. 1.15 0.28)
compared to the well-nourished patients. NPCR showed no correlation
with serum albumin value, total body muscle, lean body mass and Kt/Vurca.
It revealed a weak positive correlation with RRF, TW-Kt/V (total weekly
Kt/Vurca) and TWR-Kt/V (total weekly Kt/Vurea including RRF). In
conclusion, nutritional support and adequate dialysis should be empha-
sized in patients with longer hemodialysis duration and lower blood urea
nitrogen. NPCR and Kt/V,,r,a appear to be a more sensitive measure of
nutritional status assessed by SGA in hemodialysis patients than anthro-
pometry and other biochemical parameters such as serum albumin.
Therefore, regular follow-up of NPCR and Kt/V,.r,, with an adequate
adjustment of dialysis prescription may contribute to improve the nutri-
tional Status of patients. Further prospective study is needed to evaluate
the exact relationship between dialysis dose and nutritional status of
hemodialysis patients.
Serum prolactin level in patients undergoing long-term hemodialysis.
J.H. Kim, SM. Oh, KH. Lee, iS. Song, KT Cheon, S.K Park, S.K Kong,
Department of Medicine, Chonbuk National University Medical School,
Chonju, Korea. The kidney plays an important role in the excretion and
catabolization of hormones. The possible role of hyperprolactinemia in
the sexual abnormalities of patients with ESRD was studied in 11 patients
undergoing hemodialysis (HD). Men (N = 11)were aged 40.1 year (mean)(range: 18 to 56). The patients had been receiving HD for 38.5 months
(mean) at the time of the study. Basal prolactin levels were measured in
blood with drawn just prior to dialysis (2095.8 24.8 mIU/liter) and also
at the end of the same dialysis session (2341.3 25.1 mIU/liter). In
summary, patients undergoing hemodialysis are prone to have clinically
significant hyperprolactinemia that may impair their sexual function.
Relationships between change of serum lipid peroxide level during
hemodialysis and endogenous serum antioxidants. GB. Choi, D.H. Kong,
KJ. Yoon, Department of Internal Medicine, College of Medicine, Ewha
Womans University, Seoul, Korea. Membrane bioincompatibility induce
neutrophils to release of oxygen free radicals, resulting in cell membrane
attack through peroxidation of polyunsaturated fatty acids. To investigate
the relationships between the change of serum lipid peroxide level during
hemodialysis and the endogenous serum antioxidants, we measured serum
lipid peroxide by using thiobarbituric acid test reaction, serum ceruloplas-
mm, transferrin, and vitamin C. Thirty-four ESRD patients maintained on
hemodialysis and 11 CRF patients were studied. Serum lipid peroxide
level were measured just before initiation of hemodialysis and 30 mm
thereafter. Serum ceruloplasmin, transferrin, and vitamin C were mea-
sured just before initiation of hemodialysis. Serum lipid peroxide levels
obtained from hemodialysis patients were seemingly lower than from CRF
patients (6.9 3.77 vs. 12.6 8.32 nmol/ml, P = 0.051). We found that
significant amount of lipid peroxide were eliminated through dialyzer
membrane during hemodialysis. In 11 patients, serum lipid peroxide level
increased significantly from a basal level of 5.0 2.03 nmol/ml to a 6.1
2.40 nmol/mI 30 mm after hemodialysis (P < 0.05), but in 23 patients
decreased significantly from a 7.9 4.06 nmol/ml to a 5.9 2.36 nmol/ml
(P < 0.00). Among 5 patients with low serum ceruloplasmin level (< 25
mg/dl), serum lipid peroxide level increased 30 mm after hemodialysis in
4 patients. In contrast, among 29 patients with normal or high serum
ceruloplasmin level (> 25 mg/dl), serum lipid peroxide level decreased 30
mm after hemodialysis in 22 patients. So, the change of serum lipid
peroxide level during hemodialysis was related to the serum ceruloplasmin
level (P < 0.05). But the change was not related to the serum transferrin
or vitamin C level. These results suggest that ceruloplasmin play a
important role in the protection from oxidation injury, and ceruloplasmin
deficiency may be one of the causes of the pathological process induced by
membrane bioincompatibility.
Plasma endothelin concentration during recombinant human erythro-
poietin (rHuEpo) administration in maintenance hemodialysis patients.
D.H. Kong, KB. Choi, KI. Yoon, Department of Internal Medicine, College
of Medicine, Ewha Women's University Hospital, Seoul, Korea. The patho-
genesis of hypertension occurring during correction of anemia with
rHuEpo in end-stage renal disease patients still remains unclear. Endo-
thelial cells have receptors for rHuEpo and release of endothelin (ET),
one of the most potent vasoconstrictor, with endothelial damage. Al-
though several studies revealed the possible link of rHuEpo treatment and
ET release, there were discordant data about rHuEpo-induced hyperten-
sion and plasma ET concentration. The present study was undertaken to
evaluate the correlation between changes in plasma ET concentration and
an increase of blood pressure during rHuEpo administration in 14
hemodialysis patients (M:F 8:6) with the measurement of hemodynamic
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parameters. rHuEpo was started at a dose of 2000 unit, given subcutane-
ously two or three times a week, at the end of each dialysis session.
Various parameters including hematocrit (Hct), erythropoietin and endo-
thelin concentration were measured before treatment and two weeks
interval during the first eight weeks of rHuEpo. We also evaluated stroke
volume (SV), cardiac index (Cl) and total peripheral vascular resistance
(TPVR) by doppler echocardiography before and eight weeks after
rHuEpo. Mean Hct and erythropoietin level before rHuEpo was 20.4
6.7% and 5.5 2.1 mU/mi, respectively, and started to increase signifi-
cantly 2 weeks after rHuEpo. Plasma ET concentration before rHuEpo
was 2.9 1.2 pg/mI, and there was no significant correlation between ET
level and systolic or diastolic blood pressure. No significant changes in
plasma ET were found during rHuEpo. After eight weeks of rHuEpo, SV
(58.4 7.3 vs. 49.7 6.5 mI/rn2, P < 0.01) and CI (4.22 0.66 vs. 3.17
0.71 liter/min/m2, P < 0.05) decreased significantly with an increase of
TPVR (1223 51 vs. 1719 34 dyn sec/cm5, P < 0.01). An elevation in
blood pressure was found in four patients (28.6%). In these rHuEpo-
induced hypertension groups, the absolute value of SV before and eight
weeks after rHuEpo was significantly lower compared to the group
without rHuEpo-induced hypertension (9.8 4.1 vs. 1.7 5.4,P <0.01),
in spite of no significant differences of zHct, erythropoietin, ET and
TPVR according to the presence of rHuEpo-induced hypertension. In
conclusion, rHuEpo-induced hypertension was not related to the rate of
Hct increase, erythropoietin and endothelin concentration during rHuEpo
administration. The most important factor which distinguished those
patients whose blood pressure rised from the remainder was a failure of
stroke volume to fall. Therefore, volume status of patients should be
carefully monitored with correction of anemia with rHuEpo in hemodial-
ysis patients.
Endotoxin level in dialysis systems. S.K Kang, KS. Lee, J.H. Kim, J.K
Koh, S.K Park; Department of Medicine, Chonbuk National University
Medical School, Chonju, Korea. All bacterial cell walls contain peptidogly-
can (PGG), and gram-negative bacteria contain an extra layer in the cell
wall structure called the outer membrane, which is outside the PDG layer.
Endotoxin (ET) is a component of this outer membrane. Endotoxin is
generally a heat-stable toxin, has various biological activities such as
pyrogenicity, macrophage and complement activation. The high perfor-
mance membrane (HPM) dialyzers can remove large molecules like
10,000 molecular wt ones in blood. In other words, 10,000 molecular wt
molecules in dialysis solutions can come into blood. Some dialysis patients
are troubled with fever from an unknown origin. It is assumed that
pyrogens in dialysis solutions come into blood through dialyzers. A typical
pyrogen is endotoxin. The condensed solutions are diluted with reverse
osmosis (RO) water. Since the pore size of RO membrane is veiy small,
endotoxin can be removed. The RO stored water is one of the source of
endotoxin. The dialyzer inlet part connects tubing to dialyzer and is often
contaminated with bacteria. To protect the dialysis solution from bacterial
and endotoxin contamination, we are proposed measures ET in the
dialysis system by toxinometer (Limulus test, Wako) at 9 dialysis centers in
Korea. A RO system appeared necessary for decreasing ET in tap water
to a certain concentration so ET in the dialysate would be minimal.
Effects of increasing blood flow rate (BFR) on KTIVra and dialytic
complications in hemodialysis (HD) patients. S.K Shin, I-IS. Kim, and
D.H. Kim, Department of Nephrology, School of Medicine, Ajou University,
Suwon, Korea. The amount of dialysis is an important factor on the
prognosis of the HD patients, and urea clearance increases as BFR
increases during the certain level of BFR. Whether the dialytic complica-
tions are affected by the variable levels of BFR on hemodialysis is still
controversial. We evaluated KT/Vur and dialytic complications accord-
ing to the variable BFR in the HD patients. Fifteen HD patients who had
been clinically stable during the last 4 months in Ajou University Hospital
dialysis unit were enrolled. A total of 8 weeks of study were processed with
each patients by randomizing the BFR 200 (N = 70), 250 (N = 68), 300
(N 60), 350 (N = 34) mI/mm for 2 weeks each. On each HD session,
KT/V, was measured and intra-, inter-dialytic symptoms, 14 each, were
asked in a questionnaire. The male:female ratio was 10:5 and the mean
age 41.4 11.9 years. Mean duration of HD was 20.6 28.3 months. The
values of KT/V,rea increased significantly (P < 0.01) according to the
increment of BFR except on the BFR 350 mI/mm (200 mI/mm, 1.11
0.30; 250 mI/mm, 1.20 0.18; 300 nil/mm, 1.30 0.20; 350 nil/mm, 1.27
0.26). The mean arterial pressure and hypotensive episodes were not
statistically different among the 4 different BFR groups. Among the 14
mnterdialytic symptoms, only thirst and pruritus were statistically different
among 4 groups, and among the 14 intradialytic symptoms only general
weakness were different. The increment of BFR resulted in increment of
KT/Vurea without severe adverse effect on intra- or interdialytic symptoms.
Incidence of hypercalcemia in dialysis patients: LID vs. CAPD.J.H. Kim,
MS. Park; E.Y Lee, M.K. Cha, K!. Song, D.C. Han, S.D. HwangandH.B.
Lee, Hyonam Kidney Lab., Soon Chun Hyang University, Korea. The use of
phosphate (P) binders and high calcium (Ca) dialysate has been a standard
therapy for dialysis patients. The use of Ca containing phosphate binders,
however, has resulted in hypercalcemia in a substantial portion of dialysis
population, and hence the need for a low Ca dialysis fluid has arisen. In
the present study we evaluated the incidence of hypercalcemia among 180
dialysis patients (116 on HD and 64 on CAPD) at the Kidney Center, Soon
Chun Hyang University Hospital. Dialysate Ca concentrations were 3.0
mEq/liter and 3.5 mEq/liter for HD and CAPD, respectively. Calcium
carbonate was used by 114 HD and 64 CAPD patients and oral calcitriol
by 26 HD and 3 CAPD patients. Serum Ca, ionized Ca (iCa), P, albumin
(AIb), bicarbonate (HCO3), alkaline phosphatase (Alk P) were measured
monthly and PTH measured once every 6 months. Total Ca level was
corrected by serum albumin level (Ca) and hypercalcemia was defined as
over 10.5 mg/dl. None of the patients were hypercalcemic pre-HD,
while 44 HD patients (37.9%) were hypercalcemic post-dialysis. When
pre- and post-HD Ca were averaged, 14 HD patients (12.1%) were
hypercalccmic, while 5 CAPD patients (7.8%) were found to be hypercal-
cemic. Average pre- and post-HD Ca (9.7 0.7 mg/dl vs. 9.2 0.8 mg/dl,
P < 0.01) and iCa (1.10 0.11 mmol/liter vs. 1.05 0.01 mmol/liter, P <
0.01) were significantly higher, and P (4.2 1.0 mg/dl vs. 5.0 1.2 mg/dl,
P < 0.01) significantly lower in HD than in CAPD. AIb (4.0 0.5 rng/dl
vs. 3.6 0.6 mg/dl, P < 0.01) was significantly higher in HD than in
CAPD. HCO3 (18.9 1.8 mmol/liter vs. 25.2 3.4 mmol/liter, P < 0.01)
was significantly lower in HD than on CAPD. PTH was significantly higher
on HD than on CAPD (P < 0.01) Alk P did not differ between the two
groups. Daily consumption of CaCO3 was higher on HD than on CAPD
(2.8 g vs. 2.2 g, P < 0.01). In conclusion, the incidence of hypercalcemia is
high in our HD patients post-dialysis but not pre-dialysis.
Increased interdialytic weight gain is associated with better biochemi-
cal indicies of nutrition in chronic hemodialysis patients. SN. Yun, YS.
Shin, H.C. Song, S.f. Ahn, W.S. Koo, E.J. Choi, YS. Chang, and B.K Bang,
Department of Internal Medicine, Catholic University Medical College, Seoul,
Korea. It had been considered that the mnterdialytic weight gain in chronic
hemodialysis patient was due to water intake. The study was undertaken to
determine the effect of interdialytic weight gain on the biochemical
indicies of nutrition in the assumption that increased weight gain might be
associated with increased food intake as well as increased water ingestion.
The 47 patients with maintenance hemodialysis (3 times/week) were
classified into two groups according to the percent increase of interdialytic
weight gain to dry weight: group 1 (5%, N = 20) and group 2 (<5%, N =
27). The sex, dialysis duration and causes of chronic renal failure were not
significantly different between groups but the age (42 15 in group 1 vs.
53 15 in group 2, P = 0.017) and the dry weight (47.0 9.4 kg in group
1 vs. 57.0 7.3 kg in group 2, P = 0.0004) were significantly different
between groups. The value of predialysis BUN (89.80 14.99 vs. 75.84
19.93 mg/dl,P = 0.0118), albumin (4.44 0.34 vs. 4.19 0.39 mg/dl,P =
0.0307) and Kt/V (1.51 0.17 vs. 1.36 0.25, P = 0.0297) in group 1 were
higher than those in group 2. The value of total protein, cholesterol,
triglyceride and NPCR were not significantly different between groups. In
conclusion, increased weight gain was associated with better biochemical
indicies of nutrition in young patient with adequate dialysis.
Body composition assessment with bioelectric impedance analysis in
hemodialysis patients. D.C. fin, W.S. Koo, J.H. Lee, S.Y. Kim, and B.K
Bang, Department of Internal Medicine, Catholic University Medical College,
Korea. The body water gain assessment is one of the most important factor
in hemodialysis patient care for prevention of complication, that is,
congestive heart failure. The total body water before and after dialysis and
fat composition of the maintenance hemodialysis patients were assessed
with bioelectric impedance analysis. A total of 135 end-stage renal disease
patients (59 male, 76 female) were enrolled the study (mean hemodialysis
duration 44.0 months; mean dialysis times per week 2.27). Each of two
electrodes were attached on the wrist and ankle for bioelectric impedance
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measurement with 800 jzA, 50 kHz alternative current and total body
water, % fat, fat free weight were calculated. Before the hemodialysis,
mean body weight was 61.0 7.2 kg, mean % fat was 13.9 7.0%, total
body water/body weight ratio was 0.646 0.06 in male patients and 51.7
8.6 kg, 22.0 7.1%, 0.588 0.06 in female patients, respectively. After
the hemodialysis, mean body weight was 58.5 7.0 kg, mean % fat was
18.3 7.8%, total body water/body weight ratio was 0.606 0.06 in male
patients and 49.2 8.4 kg, 27.3 7.7%, 0.553 0.06 in female patients,
respectively. The reduction of total body water was assessed greater than
body weight reduction. The bioelectric impedance analysis may be very
helpful for assessment of dry weight, weight reduction by ultrafiltration,
nutritional status of each hemodialysis patient.
The evolution of HCV infection according to the mode of dialysis in
patients with end-stage renal disease (ESRD). SW. Lee, SW. Kang, KH.
Choi, H. Y Lee, D.S. Han, Department of Internal Medicine, Yonsei Univer-
sity College of Medicine, Seoul, Korea. To investigate the effect of different
mode of dialysis (HD and CAPD) on viremia and liver function, we
examined HCV-RNA and liver function in anti-HCV positive ESRD
patients every three months for one year. The patients were 23 (12 in HD,
11 in CAPD), whose mean ages were 53.4 14.0 years, 56.5% were male,
and median duration of dialysis was 74.9 (27.3 to 137.3) months. Between
HD and CAPD, no significant differences were seen in percentage and
number of transfusion, serum ALT, ferritin, YGTP, the positivity of
antiHBc; however, the difference in the duration of dialysis (109.8 months
in HD vs. 58.2 months in CAPD, P < 0.05) were significant. The incidence
of anti-HCV positive patients was significantly high in HD group, with
22.6% (12/53) compared to 3.0% (11/364) in the CAPD group (P < 0.05).
Of those, one patient on HD and two patients on CAPD expired due to
sepsis. Two cases of seroconversion to anti-HCV positive were noted in
HD, but none in CAPD. Two CAPD patients were switched to HD due to
fungal peritonitis. Between HD and CAPD, no significant differences were
seen in the incidence of chronic hepatitis (16.7 vs. 18.2%) and the
positivity of HCV-RNA (83.3 vs. 90.0%). HCV-RNA positive (N = 20)
and negative (N = 3) groups, divided from the anti-HCV positive patients
showed no significant difference in the percentage and number of trans-
fusion, mode of dialysis, and the incidence of chronic hepatitis, serum
ferritin, yGTP, and the positivity of antiHBc, except in serum AST (27.2
22.3 vs. 7.0 3.0 lU/liter, P < 0.05) and ALT (35.0 27.6 vs. 7.0 3.0
lU/liter, P < 0.05). In conclusion, viremia and liver functions were not
significantly different in various mode of dialysis. A large patient sample
and a long-term study are needed to conclude the efficacy of HD or CAPD
in protecting liver in anti-HCV positive ESRD patients.
Effect of hemodialysis on levels of malondialdehyde and superoxide
dismutase in patients with chronic renal failure. H-C. Kim, S-B. Park, J.
Suk, I. Joo, K -C. Mun, and C. -S. Kwak, Department of Internal Medicine
and Biochemistry, Keimyung University School of Medicine, Taegu, Korea.
Effect of hemodialysis on the levels of the lipid peroxidation product
malondialdehyde (MDA), and one of the oxygen free radical scavenger
superoxide dismutase (SOD) were determined before and after hemodi-
alysis in the erythrocytes (RBC5) and plasma from 20 patients with chronic
renal failure (CRF), and from 14 healthy subjects. The amount of MDA
was measured by the method of thiobarbituturic acid assay which is based
on MDA reacts with thiobarbituric acid to give a red species absorbing at
535 nm. Superoxide dismutase was assayed using alkaline dimethylsulfox-
ide as a superoxide anion-generating system in association with cyto-
chrome c as a superoxide anion-indicating scavenger by the method of
Hyland et a!. One unit of its activity was defined as the amount which
inhibited the reduction of cytochrome c by 50%. Before dialysis, MDA
level in chronic uremic patients was higher than that in healthy controls,
while SOD activity was lower. This result suggested that enzymatic
antioxidant defense mechanism is suppressed, and lipid peroxidation is
increased in the RBCs, other cells and tissues from the patients with CRF.
After hemodialysis, MDA and SOD in the RBCs and plasma from the
patients with CRF were normalized. This result indicates that hemodial-
ysis is helpful to protect the peroxidative damage through normalizing
SOD activity.
Methicillin-resistant Staphylococcus peritonitis in patients on CAPD.
N.H. Kim, YJ. Kwon, JR. Ku, S.K Jo, YS. Kim, KS. Wee, DR. Cha, WY
Cho, Hf. Pyo, and J-I.K Kim, Department of Internal Medicine, College of
Medicine, Korea University, Seoul, Korea. Staphylococcus is the most
common pathogen in CAPD peritonitis. Recently methicillin-resistant
Staphylococcus (MRS) infections are the leading cause of hospital ac-
quired infections and occupy about 5—30% of CAPD peritonitis. We
compared the clinical manifestations, treatments, and outcomes between
methicillin resistant Staphylococcus (MRS) peritonitis (27 episodes in 16
patients) and methicillin sensitive Staphylococcus (MSS) peritonitis (23
episodes in 16 patient) that occurred during the recent 4 years. (1) The
mean age and male/female ratio of MRS and MSS groups were 51.5 years
vs. 49.6 years and 1:0.79 vs. 1:0.79, respectively. (2) The underlying
diseases were CGN (69% vs. 56%), hypertension (13% vs. 6%), DM (19%
vs. 25%). (3) The incidence of preceding peritonitis (episodes/
patient - month) was 0.077 vs. 0.029 and the incidence of preceding
exit-site infection (episodes/patient month) was 0.006 vs. 0.00 18. (4) The
4.25% prescription (number/day - patient) was 0.44 vs. 0.25 (P <0.05) and
2.5% prescription (number/day - patient) was 0.25 vs. 0.25. (5) The
duration of CAPD was 19.6 months vs. 37.7 months (P < 0.05). (6) The
time from the onset of CAPD to MRS peritonitis episode was 313 334
days vs. 700 599 days (P < 0.05). The time from the latest peritonitis to
current infection was 116 days vs. 265 days (P < 0.05). (7) The modality of
treatment was antibiotics with or without catheter exchanges in MRS
group and was antibiotics only (96%) in MSS group. But there was no
difference in treatment outcomes, recurrences of peritonitis, and mortal-
ities between MRS and MSS groups. In conclusion, MRS peritonitis was
preceded by frequent peritonitis episodes and exit-site infections and was
associated with higher rates of catheter exchange than MSS group.
The risk factors associated with early death in patients with catheter
removal due to peritonitis. S. Cho, S.f. Kim, MY. Paik, J.H. Kim, J.H.
Bang, TH. Kwon, YL. Kim, and D.K Cho, Department of Internal
Medicine, Kyungpook University Hospital, Taegu, Korea. To evaluate risk
factors associated with early death (within 3 months) after catheter
removal due to peritonitis, we reviewed 28 patients among 219 CAPD
patients between January 1988 and March 1995 in Kyungpook University
Hospital. Eight patients died within 3 months after catheter removal
(G-1). Fourteen patients were alive beyond 12 months after catheter
removal (G-2). Using chi-square analysis, age, sex, CAPD duration,
diabetes mellitus, liver cirrhosis, cardiac disease, frequency of peritonitis,
etiologic organisms, exit site infection, tunnel infection, abdominal ab-
scess, serum albumin level, serum cholesterol level, and duration from
final peritonitis to catheter removal were compared. There was increased
frequency of liver cirrhosis, cardiac disease, and exit site infection at the
time of catheter removal in G-1 compared to G-2 (P < 0.05). G-1 tended
to have old age, hypoalbuminemia, and hypercholesterolemia compared
to G-2 (X2M-H test for linear association, P = 0.1480/0.0540/0.0965), while
sex, CAPD duration, diabetes mellitus, frequency of peritonitis, etiologic
organisms, tunnel infection, abdominal abscess, or duration from final
peritonitis to catheter removal had no significant adverse effects on early
death. In summary, the risk factors associated with early death after
catheter removal due to peritonitis were liver cirrhosis, cardiac disease,
and exit site infection at the time of catheter removal.
Outcome on CAPD after renal transplant failure. TH. Kwon, YL. Kim,
D.K. Cho, and Y W Kim, Department of Internal Medicine, Department of
Surgery, Kyungpook University Hospital, Taegu, Korea. To assess whether
patients failing renal transplant and commencing continuous ambulatory
peritoneal dialysis (CAPD) for the treatment of end-stage renal disease
(ESRD) have high risk of infective and catheter-related complications, we
retrospectively reviewed the clinical outcome of 8 patients failing renal
transplant and commencing CAPD (Group A). Then, for each of these
patients, 16 comparison subjects were chosen from CAPD patients of our
hospital; matching variables were age, sex, CAPD duration and underlying
disease of ESRD (Group B). In Group A, 8 patients (4 males/4 females)
with a mean age of 35 8.9 years had graft survival of 26.5 16.4 months
and were treated with CAPD for 31 23.9 months post-transplant.
Immunosuppressive agents were not administered after commencement
of CAPD. After renal transplant failure, 3 patients developed pancytope-
nia, 2 had hepatitis B-related chronic liver disease, 1 of whom had a gastric
ulcer. In Group B, 16 patients (8 males/8 females) with a mean age of 36
10.6 years were treated with CAPD for 31.8 22.9 months. Among
them, 3 patients developed hepatitis B-related chronic liver disease. The
peritonitis and exit site infection rates were similar in Group A (1 per 14.7
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patient-months/I per 13.2 patient-months) and Group B (1 per 13.2
patient-months/i per 36.3 patient-months). The leakage rates were simi-
lar: 3/10 catheters developed pericatheter leaks for a percentage rate of
30% in Group A and 3/17 catheters developed pericatheter leaks for a
percentage rate of 17.6%. The catheter removal rates were similar in
Group A (0.19/patient-year) and Group B (0.09/patient-year). One death
was a result of sepsis 5 months post-CAPD in Group A. Although the
small sample size in this study limited definite conclusions, patients
commencing CAPD after renal transplant failure had similar infective and
catheter-related complications and did not have a particularly poor
outcome.
CAPD in end-stage renal disease patients with pre-existing liver
cirrhosis. YL. Kim, T.H. Kwon, and D.K Cho, Department of Internal
Medicine, Kyungpook University Hospital, Taegu, Korea. The spontaneous
tendency to arterial hypotension in cirrhotic patients makes adequate
hemodialysis therapy extremely difficult. Hemodialysis in these patients
may produce intradialytic hypotension, limiting the amount of ultrafiltra-
tion. These patients are also at high risk for gastrointestinal bleeding,
which can be exacerbated by anticoagulation. Recently, peritoneal dialysis
has been suggested for the management of this population. Seven patients
with chronic renal failure and liver cirrhosis treated by CAPD are
described. Six of the seven patients were complicated by ascites upon
starting CAPD. Hepatocellular carcinoma was identified in one patient.
Three had been transferred from hemodialysis for hemodynamic intoler-
ance, and one for a vascular access problem. All PD catheters were
surgically placed. The hemodynamic tolerance was excellent in all pa-
tients. Four patients developed bleeding immediately after catheter
insertion. Two patients developed early leaks and one patient developed a
late leak. Four patients had a decline in serum albumin level of 0.5 g/dl or
more during the course of chronic PD. Peritonitis occurred on average at
8.6 month intervals. Three episodes of catheter removal occurred in 147
patient-months of PD (0.24 per patient-year). Four patients died while
maintained on PD; three deaths were due to hepatic encephalopathy on
PD for duration of 4 to 60 months and the fourth was due to peritonitis
after 24 months of PD. One patient died due to malnutrition after 2
months while switching to hemodialysis because of peritonitis after 32
months of PD. Early mechanical complications after catheter insertion
(bleeding, leak) were more common than usual. But CAPD was better
tolerated than hemodialysis and may be a reasonable choice with an
acceptable survival rate in end-stage renal disease patients with pre-
existing liver cirrhosis.
The clinical study in fungal peritonitis in patients on CAPD. N.H. Kim,
YJ. Kwon, JR. Ku, M.K Jang, YH. Lee, YS. Kim, D.R. Cha, W.V. Cho, H.J.
Pyo, and H.K Kim, Department of Internal Medicine, College of Medicine
Korea University, Seoul, Korea. CAPD peritonitis is one of the most
important complications of peritoneal dialysis. Among the CAPD perito-
nitis, fungal peritonitis is relatively rare but the prognosis is poor and the
removal of peritoneal catheter is frequent treatment modality. We com-
pared the clinical manifestations, treatments, and Outcomes between 15
episodes of fungal peritonitis in 15 patients and the remainder (100
patients) during the past 4 years. (1) The mean age and male/female ratio
of fungal and control group were 46.7 years vs. 50.8 years and 1:0.89 vs.
1:0.85, respectively. (2) The underlying diseases were CGN (60% vs. 52%),
hypertension (6.7% vs. 11%), DM (26.7% vs. 22%). (3) The incidence of
preceding peritonitis (episodes/patient - month) was 0.008 vs. 0.001 and
the incidence of preceding exit site infection (episodes/patient - month)
was 0.002 vs. 0.0005. (4) The 4.25% prescription (number/day. patient)
was 0.46 vs. 0.27 and 2.5% prescription (number/day patient) was 0.06 vs.
0.20. (5) The duration of CAPD was 8.8 months vs. 19.6 months. (P <
0.05). (6) The time from the onset of CAPD to fungal peritonitis episode
was 263 247 days, the time from the latest peritonitis was 26.3 days, and
the time from the cessation of antibiotics was 18.7 days. (7) The treatment
was catheter change with or without antifungal agent. There was no
significant difference in outcomes between these two treatment modalities.
In conclusion, there was no significant risk factor in fungal peritonitis and
it occurred mostly within 1 month after cessation of antibiotics. The
episodes of fungal peritonitis were treated by catheter removal with or
without antifungal agent. There was no significant difference in morbidity
and mortality between these two treatment modalities.
The effect of dialysis dose/on preservation of lean body mass (LBM) in
continuous ambulatory peritoneal dialysis (CAPD) patients. S. W. Lee,
S. W Kang, KH Choi, H.Y. Lee, and D.S. Han, Department of Internal
Medicine, College of Medicine, Yonsei University, Seoul, Korea. Malnutrition
has been reported to be as high as 40% in CAPD patients and changes in
LBM have been purported to reflect long-term nutritional status. In order
to examine the effect of dialysis dose on the preservation of LBM over
time, we retrospectively analyzed urea kinetic and creatinine excretion
data from 31 stable CAPD patients whose first kinetic study was done
within 6 months after initiation of CAPD and was followed-up every 6
months for more than 1 year. LBM was calculated according to the
formula of Keshaviah. The patients were divided into two groups: group I
in whom LBM at 12 months declined more than 5% from month 0 value
(N = 14); group II whose LBM remained unchanged or increased (N =
17). In group I, weekly Kt/V urea at 6 months (2.00 0.41) was similar to
month 0 (2.18 0.16) but it decreased significantly at 12 months (1.89
0.38, P < 0.05 compared to month 0). There were no significant changes
in weekly Kt/V in group H during the follow-up period (2.23 0.57, 2.17
0.71, 2.07 0.63 at 0, 6, and 12 months, respectively). BUN, NPCR,
residual renal function, urinary creatinine excretion and weekly C.
decreased significantly (P < 0.05) at 12 months in group I, but not in group
II. Serum creatinine and dialysate creatinine excretion increased signifi-
cantly (P < 0.05) at 12 months in group II, but not in group I. Body wt,
BMI and serum albumin were unchanged in both groups during the
follow-up period. When the patients were divided into two groups
according to the mean weekly Kt/V over 12 months, the LBM at 12
months as percentage of month 0 decreased significantly (95.0 10.3%,
P < 0.05) in the patients with low mean weekly Kt/V (N = 16, 1.76
0.23), but in patients with high mean weekly KtIV (N = 15, 2.45 0.43)
the LBM remained unchanged (98.5 12.3%, P> 0.05). The mean LBM
did not correlate with mean serum albumin, NPCR, residual renal
function, weekly C. and weekly Kt/V. Mean residual renal function
correlated positively with mean weekly Kt/V (r = 0.76) and weekly Cr
(r = 0.88). In conclusion, the preservation of LBM may be affected by the
dialysis dose and it is important to monitor the dialysis dose and LBM in
CAPD patients regularly because modification of dialysis dose may
prevent this loss of LBM.
The effect of ouabain on peritoneal transport characteristics. M. S. Park
0. Heimburger, J. Waniewski, A. We,ynski, H.B. Lee, and B. Lindholm,
Hyonam Kidney Laboratory, Seoul, Korea, and Karolinska Institute, Stock-
holm, Sweden, Polish Academy of Sciences, Warsaw, Poland. Fluid and
solute transport during peritoneal dialysis (PD) is believed to be passive,
mainly diffusive, and partially convective. Other transport mechanisms
than passive transport may, however, also be involved. Intracellular
transport of potassium in cultured mesothelial cells is reported to be
regulated by a channel that is blocked by ouabain. High glucose and
therefore high insulin in the peritoneal cavity may promote extra- to
intracellular shifts of potassium during peritoneal dialysis. To investigate
the role of ouabain-blocked K channel in peritoneal transport, a 4-hour
single peritoneal dialysis was performed in 16 normal Sprague-Dawley
rats. Conventional dialysis solution (Dianeal 3.86%, pH 5.7) containing
sufficient K (5.0 0.3 mmol/liter) to minimize diffusive transport of K with
(PD-O) and without (PD-c) ouabain (10—i M) was used in 8 rats each.
Infusion volume was 30 ml. Intraperitoneal dialysate volume (V0) was
estimated from the dilution of volume marker, 131J human serum albumin
(RISA), with corrections for the elimination of RISA from the peritoneal
cavity (Ks, ml/min) and sample volume. The diffusive transport coefficient
(KBD) and the sieving coefficient (5) were estimated using modified
Babb-Randerson-Farrell model. D/P K at the beginning of dialysis was 1.2
0.1. VD was significantly higher (P < 0.05) in PD-O than in PD-C from
120 minutes of dialysis. KE (0.058 0.003 vs. 0.027 0.018, P < 0.05) and
fractional amount of glucose absorption were significantly lower in PD-O
than in PD-C from 90 minutes of dialysis. and S values for urea,
glucose, sodium and K did not differ between the two solutions. Ouabain
decreased the peritoneal fluid reabsorption and decreased peritoneal
glucose absorption, and therefore increased VD. Peritoneal transport of
small solutes including K was not influenced by ouabain during peritoneal
dialysis with an acidic dialysis solution in rats.
Effect of prolonged subcutaneous implantation of peritoneal catheter
on peritonitis rate during CAPD. MS. Park E.Y. Lee, MK Cha, J.H. Kim,
KI. Song, D.C. Han, S.D. Hwang, C. Moon, and H.B. Lee, Hyonam Kidney
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Laboratoty, Soon Chun Hyang University, •, Korea. We have previously
reported in an uncontrolled study that peritonitis (P) incidence was
reduced with the introduction of a new access technique, as described by
Moncrief, in which the external segment of peritoneal catheter was left
implanted for 6 weeks before exteriorization and bag exchanges. We
therefore conducted a prospective randomized controlled study to confirm
the earlier observation. Patients who started CAPD between October 1992
and December 1994 and who remained on CAPD for more than 3 months
were included in this analysis. A total of 59 CAPD patients were
randomized into 2 groups: 27 patients had catheters inserted by conven-
tional technique (C) and had 6 weeks of break-in period and 32 patients
had catheters left implanted subcutaneously for 6 weeks (I). Thirteen
patients (48.1%) from group C and 18 (56.3%) from group I used Y
connectors (CY and IY) and the remaining patients from each group used
straight connectors (CS and IS). Age, sex, and proportion of diabetics
were not different between the two groups. The observation period was
264 months for C and 438 months for I, for a total of 703 months. The
incidence of P was significantly lower in group I compared with group C,
regardless of connectors (14.8 vs. 8.8 months, P < 0.05). The incidence of
P was lowest in group IY while this was the highest in group CS (18.1 vs.
7.5 months, P < 0.05). In conclusion, prolonged subcutaneous implanta-
tion of peritoneal catheter significantly reduced the P rate and the use of
Y connector further reduced P rate.
Peritoneal dialysis in treatment of metabolic crises caused by inherited
disorders of organic and amino acid metabolism. J.H. Kang, D. W. Lee,
SM. Shin, and E.M. Kim, Department of Pediatrics, Soonchunhyang
University Hospital, s, Korea. Six patients (8 cases, M:4, F:2) with metabolic
crises due to inborn error of metabolism were treated with peritoneal
dialysis (PD). We hereby report on treatment results for metabolic crises
caused by inherited disorder of organic acid and amino acid metabolism.
Underlying diseases were OTC deficiency in 4 patients (6 cases) and 1 case
each of propionic acidemia and multiple carboxylase deficiency (MCoD).
Five patients (7 cases) had hyperammonemia and 1 had severe metabolic
acidosis. The former were treated by commercial dialysate solution, the
latter with custom-made bicarbonate bath. Mean age of 6 neonate patients
was 7.67 days, of which 2 were retreated with PD at 2 and 9 months. Mean
serum ammonia level was 1000.17 e,g!dl, but dropped to under 300 Wdl
88.66 hours after initiatioi. Mental status improved in 4 patients at 19.75
hours, with means of 282.23 ,tLgIdl serum ammonia level and treatment
15.55 hours after unset of symptoms. Three other patients were treated 23
hours after symptom onset, hut expired with a level of 847.5 e,g!dl. Severe
metabolic acidosis with propionic acidemia improved in the other patient
19 hours after PD, but mental status did not improve. Leucine, isoleucine
and valine levels decreased for the MCoD case. In conclusion, 4 out of 7
cases (57%) of hyperammonemia survived with PD. So therapeutic effect
was very positive. The treatment of metabolic acidosis was also effective
although the patient expired. Further study is needed.
Clinical study of continuous ambulatory peritoneal dialysis in children.
W.K Choi, MJ. Kwon, and P-K Kim, Department of Pediatrics, Yonsei
University College of Medicine, Seoul, Korea. CAPD has established itself as
an alternative therapeutic modality to hemodialysis in the treatment of
patients with end-stage renal disease. Especially in children, many of the
advantages originally reported with the use of CAPD have been reported
with large population studies. This includes easy training and manage-
ment, no requirement of repetitive venopuncture, less restriction of diet,
stable salt and water balance, and easy blood pressure control. Clinical
studies were carried out on the 29 cases of CAPD who had been treated
from November 1985 to February 1995. The following results were
obtained: 19 cases were males and 9 cases were females, with a male to
female ratio of 1.9:1. The mean age of the patients was 12.9 3.1 years.
The original renal diseases of ESRD were proven in 22 cases. The
common renal diseases were reflux nephropathy and chronic glomerulo-
nephritis each in 4 cases. Other diseases were focal segmental glomeru-
losclerosis in 3 cases, Hcnoch-Schönlein purpura nephritis in 2 cases,
hemolytic uremic syndrome in 2 cases, as well as Alport syndrome, IgA
nephropathy, and lupus nephritis. The mean duration of CAPD was 16.1
19.9 months. Peritonitis was the most common complication, with an
incidence of 1 episode!paticnt!7.6 months. Other complications were exit
site infection in 3 cases, obstruction in 3 cases, and leakage of dialysate in
3 cases. Peritoneal adhesion, malposition and scrotal swelling also oc-
curred. The most common etiologic organisms of peritonitis were Staph-
ylococcus coagulase negative in 8 cases, Staphylococcus aureus, pseudomo-
nas, Enterococcus species, and E. coli. As renal transplantations increase
CAPD in children has become more important as a renal replacement
therapy. Although the pathophysiologic studies of patients on CAPD have
been performed, more research must be done.
Prophylactic effects of trimethoprim-sulfamethoxazole in renal trans-
plantation patients. H.K Chae, J.Y. Lee, K W. Kahng, S.M. Kim, H.J. Kim,
C.H. Park, C.M. Kang, and H. C. Park, Department of Internal Medicine,
College of Medicine Hanyang University, Seoul, Korea. Urinary infections in
renal transplantation patients occur fairly frequently and may cause
morbidity and even death. There are several reports of TMP-SMZ
(bactrim) reducing the frequency of bacterial infection, duration of febrile
period, mortality rate from infection in granulocytopenic or renal trans-
plantation patients. We studied the prophylactic effect of low dose bactrim
in renal transplantation patients, such as incidence of infection (bacterial!
nonbacterial), infection site, type of pathogen, and side effects, including
cyclosporine metabolism, and other possible factors that may influence the
occurrence of infections in renal transplantation during the 6 months after
the operation. The 66 patients were divided into 3 groups: 1st group not
taking bactrim (33), 2nd group taking bactrim only during the hospital-
ization, 3rd group taking bactrim continuously after renal transplantation.
There were no significant differences in infection incidence, including
hospital infection, outpatient infection, urinary infection, bacterial infec-
tion, nonbacterial infection and morbidity from infection among the 3
groups. There were no significant side effects of bactrim. In the bactrim
administration group, there was a lower incidence of Pseudomonas culture
in Foley catheter tip, but the results of Foley tip culture had no correlation
with infection, including bacterial, nonbacterial, hospital, and outpatient
infection. There was a lower rate of acute rejection in the bactrim group.
Bactrim had no effect on the cyclosporine level. From these results, we
concluded that bactrim in low dose (TMP 80 mg—SMZ 400 mg) has no
prophylactic effect in renal transplantation patients during the 6 months
after renal transplantation, but further study about dose increases and
rejection are needed.
The clinical outcome of IgA nephropathy (IgAN) after renal transplan-
tation.S.H. Cho, SW Lee, S.K Lee, YS.Jang, LW. Kang, KH. Choi, H.Y
Lee, D.S. Han, YS. Kim, and K. Park, Department of Internal Medicine,
Department of Surgery, College of Medicine, Yonsei University, Seoul, Korea.
To investigate the clinical course of IgAN after renal transplantation, a
retrospective analysis was conducted in a group of 179 patients who
received kidney transplantation between April, 1979 and December, 1994
with known original glomerular diseases that progressed to end-stage
renal failure. Among these, 63 (35.2%) patients had IgAN, and 116
(64.8%) patients had non-IgAN. The sex ratio was 2.5:1 and the mean age
was 35.0 years in the IgAN group. The HLA-B51 (25.4%) and HLA-DR4
(39.7%) were the most common HLA-B and -DR antigen in the IgAN
group, and HLA-DR1 was more common in the IgAN group (25.4%)
compared to the non-IgA group (7.8%; P < 0.05). The 5-year graft and
patient survival rates in the IgAN group were 79.0% and 94.0%, and in the
non-IgAN group they were 83.0% and 100%, respectively. These differ-
ences were not statistically significant. Allograft renal biopsies revealed
IgAN in 13 (4.9%) of 266 patients who underwent renal biopsy for
evaluation of microscopic hematuria, proteinuria and renal insufficiency.
Six of 13 IgAN were recurrent IgAN, 1 was de novo IgAN, and others were
unknown primary glomerular diseases. The mean duration after transplan-
tation for recurrence was 40 months (11—72), and at the time of diagnosis
as recurrent IgAN, these 6 patients had mean proteinuria of 3.2 g!day
(0.3—9.0) and renal insufficiency with serum creatinine 2.7 mg/dl (1.4—6.8).
The 5-year graft survival rate in 6 recurrent IgAN patients was significantly
lower compared to the remaining 57 IgAN patients (66.7% vs. 84.6%, P <
0.05). In conclusion, there was no significant difference in the graft and
patient survival rate between IgAN and non-IgAN patients after trans-
plantation. In addition, the recurrence rate of IgAN was relatively low
(9.5%), but if recurrent IgAN develops, the graft survival rate decreases
significantly.
Donor specific blood transfusion (DST) in living unrelated donor
(LUD) kidney transplantation. J.M. Kong, J.H. Jeong, J.K Kong, I.K
Seong, and B.C. Kim, Departments of Medicine, General Surgery and
Urology, Maiyknoll Hospital, Pusan, South Korea. Due to the severe organ
shortage, LUD kidney transplantation may be a viable option if ethically
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acceptable. While there are numerous studies on the role of DST in living
related transplantation, there are few on LUD transplantation. DST was
reported to induce donor-specific immune tolerance and improve graft
survival. However, its role has been questioned in rccent years due to
possible sensitization and overall improvement in graft survival without
DST. Previously, Cheigh et al reported a simplified DST protocol by
transfusing 100 ml of whole blood at 1, 8 and 15 days of its storage with
coadministration of cyclosporine, which produced a very low adverse
sensitization rate and an excellent graft outcome. We adopted their
protocol in LUD renal transplant patients and observed donor specific
sensitization rates and graft survival rates. Eighty-one patients received
DST from related donors in a single center between March 1991 and April
1995. At the completion of DST, only 4 (4.7%) of 85 patients developed
adverse sensitization that precluded subsequent transplantation. The
remaining 81 patients underwent kidney transplantation from their re-
spective blood donors. These included a patient who developed 1gM
anti-B antibody after DST with uneventful postoperative course. Mean
age was 37 years (21—58). The number of ABDR mismatches was 3.9
1.1. Diabetes was the cause of ESRD in S recipients. Cyclosporine and
prednisolone were the primary immunosuppressants. Acute rejection
occurred in 35 recipients (41%). Acute rejection tended to occur earlier,
while 88.6% of the first episodes were within one month post-transplant,
and most readily responded to steroid pulse therapy. Mean follow-up was
29.2 (1—49) months. There were 2 graft losses due to noncompliance with
medication. The graft survival rate at 3 years is 96%. In conclusion: (1)
DST with a small amount of stored blood, three times, under cyclosporine
coverage, produced minimal sensitization rate and outstanding graft
survival in emotionally related kidney transplantation; (2) all prospective
kidney recipients from donor related donors should receive DST in
preparation for transplantation. The adverse sensitization appears to be
sufficiently offset by the excellent graft outcome.
The clinical outcome between HBsAg and anti-HCV positive renal
allograft recipients. S. W Lee, S. W. Kang, KH. Choi, H. Y. Lee, D.S. Han,
YS. Kim, and K. Park, Departments of Internal Medicine and Surgery, Yonsei
University College of Medicine, Seou4 Korea. To investigate the clinical
Outcome in HBsAg and anti-HCV positive transplant recipients, we
analyzed the data of HB5Ag and anti-HCV positive recipients. Between
January 1988 and December 1994, 1027 patients participated in transplan-
tation, among them there were 29 anti-HCV positive patients and 33
HBsAg positive patients. The pre-transplant liver biopsy of 19 anti-HCV
positive patients revealed 7 carriers, 10 CPH, and 2 CAH, and that of 33
HBsAg positive patients revealed 14, 18, and 1, respectively. Two HCV-
RNA positive recipients, of 6 anti-HCV positive recipients tested, had
concurrent CPH in liver biopsy. One (CAH in biopsy) of 4 HCV-RNA
negative recipients converted to positive later in the study. The develop-
ment of chronic hepatitis appeared to be higher in HB5Ag positive
recipients than in anti-HCV positive patients (42.4% vs. 20.7%), but this
was statistically insignificant (P = 0.06). No differences were noted in the
episodes of acute rejection, infection, graft and patient survival between
these two groups. Likewise, no significant differences were noted in the
above categories between carrier (N = 21) and CPH (N = 28). Two (1
HB5Ag and I anti-HCV positive patients) of 3 CAH patients developed
chronic hepatitis during the follow-up and 1 HBsAg positive patient
expired due to pneumonia. However, as the anti-HCV and HBsAg
positive group (N = 62) was compared to the control (N = 914), the
development of chronic hepatitis was significantly higher than the control
(32.3 vs. 1.6%, P < 0.01) and its graft (57.9 vs. 86.5% in 5 year) and patient
survival (82.0 vs. 95.4% in 5 years) were significantly (P < 0.05) less than
the control. Positive viral serology was one of the independent risk factors
for the graft failure and mortality in multivariate analysis. When the CPH
group (N 28) was compared to the control (N = 914), its graft (64.1 vs.
86.5% at 5 years) and patient (84.7 vs. 95.4% at 5 years) survival were
significantly less than the control, and CPH in biopsy was the independent
risk factor; however, carrier state in biopsy was not the risk factor for graft
and patient survival. In conclusion, the type of virus or the degree of liver
pathology didn't appear to affect the development of chronic hepatitis,
graft and patient survival. Because the recipients with CPH were signifi-
cantly poorer in graft and patient survival than the control, however, the
CPH in liver biopsy should not be considered as a candidate in transplan-
tation.
Causes of death in living-related renal transplantation. YS. Shin, SN.
Yun, S.H. Lee, C.W. Yang, W.S. Koo, E.J. Choi, YS. Yoon, andB.K Bang,
Department of Internal Medicine, Catholic University Medical College, Seoul,
Korea. The results of renal transplantation have been improved by the
development of immunosuppressive therapies and postoperative treat-
ment, but mortality and morbidity have been reported until now. The
study was undertaken to evaluate the causes of death in living-related
renal transplantations that were performed at Kangnam St. Mary's
Hospital from May 1984 to February 1995. In the study protocol, the study
population was 667 cases, excluding cadaveric renal transplantation (N =
22) and dialysis therapy (N 112) due to graft failure. Seventy-two
recipients (11%) died after living related renal transplantation and causes
of death were infection in 31 cases (55%), cardiovascular disease in 11
cases (15%), hepatic failure in 10 cases (14%), and other causes in 20
cases (28%). Major causes of death within 1 year after renal transplanta-
tion were infection (N = 22, 55%), hepatic failure (N = 5, 13%), and
cardiovascular disease (N = 4, 10%). Causes of death over 5 years after
renal transplantation were cardiovascular disease (N = 3, 50%), infection(N = 2, 33%), and uremia (N = 1, 17%). All patients who died of hepatic
failure showed HBsAg positivity. The proportion of death due to infection
decreased, but that of death due to cardiovascular disease increased. We
concluded that early mortality after renal transplantation was associated
with infection and late mortality was due to cardiovascular disease. In
HBsAg positive patients, meticulous follow-up of liver function is re-
quired.
Prevention of peptic ulcer disease by misoprostol in cyclosporine-
treated renal transplant recipients: A prospective and randomized study.
C.W. Yang, S.H. Lee, YS. Kim, S.Y. Kim, YS. Chang, YS. Yoon, and B.K
Bang, Department of Internal Medicine, Catholic University Medical College,
Seoul, Korea. With the development of cyclosporine and H2 receptor
antagonist, peptic ulcer disease (PUD) in renal transplant recipients
decreased remarkably, but it is still a serious and life-threatening medical
problem. This study was designed to evaluate the effect of misoprostol
(protaglandin El) on preventing post-transplant PUD. Eighty-seven pa-
tients were enrolled and were randomly separated into three groups:
group 1 (N = 28, antacid + ranitidine); group 2 (N = 34, antacid +
ranitidine + Dc Nol); and group 3 (N = 25, antacid + ranitidine +
misoprostol). Anti-ulcer drugs started 1 week before renal transplantation
and were maintained after operation. A gastrofibroscopy was performed I
week before and 2—3 weeks after renal transplantation. The incidence of
peptic ulcer in group I and 2 was 50.0% (14/28) and 35.3% (12/34),
respectively (P> 0.05 group 1 vs. 2). In contrast, PUD in group 3 was 12%
(3/25) (P < 0.05, compared to group 1 or 2). Relative risk for PUD in
group 1 or 2 was 7.8 times higher than group 3. In conclusion, an anti-ulcer
regimen including misoprostol is more effective than ranitidine or De Nol
for prevention of peptic ulcers in renal transplant recipients.
Cooperative study of renal transplantation in Korean children. P. -K.
Kim, Department of Pediatrics, Yonsei University College of Medicine, Seoul,
Korea. Renal transplantation is the treatment of choice for children with
end-stage renal disease. The graft survival rate of renal transplantation has
been greatly increased with the development of immunology, operation
technique and with the use of effective immunosuppressants. We had no
overall reports about renal transplantation in children which had been
statistically analyzed from around country. We investigated the outcome
of renal transplantations performed in Korea. One hundred eighty-one
cases of renal transplantation were performed at 11 hospitals from June
1973 to October 1994. In 181 donors, 75.1% of the donors (136) were
living-related donors, and only two donors were cadaveric donors. The
common causes of pediatric end-stage renal diseases were chronic gb-
merubonephritis (19.3%), refiux nephropathy (13.8%), focal segmental
gbomerulosclerosis (13.2%), and IgA nephropathy (6.1%). The observed
graft survival rates were 94.6% and 71.2% at years 1 and 5 post-
transplantation, respectively. There was no significant difference in graft
survival rate by the source of donor, degree of HLA matching. ABO
matching was a significant risk factor affecting graft survival rate; 5 year
graft survival rate in identical ABO pairs was 76.6% compared with 47.7%
in compatible pairs (P < 0.05). The most common cause of graft failure
was chronic rejection. Therefore, we conclude that the 5 year graft survival
rate of renal transplantation in Korean children is 71.2%, and ABO
matching is a significant risk factor which affects graft survival. Chronic
rejection was the most common cause for the graft loss, so more effective
immunosuppression is needed. The importance of early diagnosis and
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proper management of reflux nephropathy should not be overlooked in
pediatric patients with recurrent urinary tract infection.
The influence of pregnancy on graft function and blood cyclosporine
levels in renal allograft recipients. C.S. Park, S.H. Lee, C. W. Yang, VS.
Kim, S.Y Kim, VS. Voon, and B.K Bang, Department of Internal Medicine,
Catholic University Medical College, Seoul, Korea. Renal allograft recipients
in pregnancy are regarded as a high risk group. To evaluate the influence
of pregnancy on graft function, blood pressure, and blood cyclosporine
(C5A) levels in renal allograft recipients, 14 pregnancies in 12 renal
transplant recipients were evaluated. Most of the patients (11/13, 85%)
showed stable serum creatinine but 2 cases (15%) showed increases in
serum creatinine due to acute rejection and preeclampsia. Acute rejection
was noted in 1 patient (7%), and it was unresponsive to OKT3 therapy.
Nine cases (82%) kept blood pressure to the level of before pregnancy.
Two normotensive cases (18%) before pregnancy developed hypertension,
and one of them had to take an antihypertensive drug even after delivery.
Maternal blood CsA levels were lower during pregnancy (273 73 vs. 129
73 nglml; P < 0.01) than before pregnancy and normalized after
delivery (273 73 vs. 214 61 ng/ml; P < 0.01). Neonates had high rates
of prematurity (3/14, 24%) and low birth weight (3/14, 24%). Cord blood
CsA level was 52% (12—77%) of maternal blood CsA concentration on the
average. In conclusion, pregnancy in renal allograft recipients is relatively
safe, but careful monitoring of serum creatinine, blood pressure, blood
CsA levels and fetal condition is needed.
Effects of misoprostol on renal function and plasma endothelin-1 level
during early postoperative stage of living renal transplant recipients. S.
Lee, S.C. Yang, D.S. Han, I.H. Lee, S.K Kim, J.H. Lee, and Hf. Kim,
Department of Internal Medicine, College of Medicine, Hangyang University,
Seoul, Korea. The effects of the vasodilatory prostaglandin El analogue,
misoprostol, on renal function as judged by serum creatinine (Sr) and the
level of plasma endothelin-l (ET-1, known as a potent vasoconstrictive
peptide) were investigated in living renal transplant recipients (N = 20) on
conventional immunosuppressives with cyclosporine A and prednisolone
during the first 28 days after transplantation (Tr). Patients receiving
misoprostol (+M) following renal transplant (N = 10) were compared to
the rest of the population (N = 10) without misoprostol (—M). In both
groups, the high baseline concentration (mean SE) of Sr before Tr was
markedly decreased within the first 7 days following Tr (+M: 7.7 1.1 to
1.3 0.1 mgldl, P < 0.001, —M: 7.3 0.8 to 2.0 0.2 mgldl, P < 0.001),
and then no further significant decrement of Sr was observed at days 14,
21, and 28 after Tr. As compared to the (—M) group, the (+M) group was
associated with a significant decrease in Sr at day 7 (1.3 0.1 vs. 2.0
0.2 mg/dl, P = 0.01); however, Sr at baseline as well as at days 14, 21, and
28 did not show any significant differences in both groups. Moreover, the
time for Sr to decrease by 50% (T112,) from the immediate pre-
transplant value was significantly reduced in (+M) group (3.13 6.2 vs.
53.7 10.4 hrs, P < 0.05). Similar to the changes of Sr following Tr, the
high baseline level of plasma ET-l was significantly decreased at day 7 in
both groups (+M: 13.1 1.0 to 2.3 0.3 pg/mI, P < 0.001, —M: 12.3
1.0 to 2.0 0.2 pg/mI, P < 0.001), but no further decrease at days 14, 21,
and 28 followed. No significant difference of plasma ET-1 levels between
both groups was noted, and also no correlation between plasma ET-1 and
5Cr was observed in the baseline values of all 20 patients before Tr as well
as those for 28 days after Tr. The incidence of acute renal dysfunction
during the study period of 28 days following Tr was lower in the (+ M)
than the (—M) group (3 of 10 vs. 7 of 10). In conclusion, misoprostol in
renal transplant recipients improves renal function only in the very early
postoperative stage (within 7 days) and reduces the incidence of acute
renal dysfunction less than 50% during the first 28 days following Tr. The
effects of misoprostol in renal transplant patients were not related to any
discernible changes of plasma ET-l, which accompanied the concurrent
changes of renal function (Sr).
The effects of hemodialysis and kidney transplantation on thyroid
function. IS. Song andf.H. Lee, Chungang Gil Hospital, Inchon, Korea. To
evaluate the effects of maintenance hemodialysis and kidney transplanta-
tion on the changes of thyroid hormones in patients with chronic renal
failure (CRF), serum T3, T4, freeT3 (FT3), freeT4 (FT4), and reverseT3
(rT3) were measured by radioimmunoassay and TSH response after TRH
stimulation was measured by immunoradiometric assay. The study popu-
lation was composed of 41 cases of normal control (Group I), 22 cases of
prehemodialysis CRF patients (Group II), 85 cases on maintenance
hemodialysis (Group III), and 10 cases who received kidney transplanta-
tion (Group IV). Serum T3 level was 139.1 36.2 ng/dl in Group 1, 104.0
42.7 ng/dl in Group II, and 100.0 37.5 ngldl in Group III. FT3 level
was 3.88 1.08 pg/mI in Group I, 2.50 1.31 pg/mI in Group II, and 1.93
1.01 pg/mI in Group III. FT4 level was 1.36 0.21 ng/dl in Group I, 0.94
0.23 ng/dl in Group II, and 0.84 0.19 ng/dl in Group III. Serum T3,
FT3 and FT4 of Group H and III were decreased compared to Group I
(P < 0.001), but there was no difference between Group II and III. Serum
T4 level was 8.37 1.27 j.g/dl in Group I, 7.79 1.41 /Lg/dI in Group II,
and 6.77 1.29 j.g/dl in Group III which was decreased compared to
Group I and II (P < 0.05). There was no difference in rT3 among the
groups. TSH response after TRH stimulation in Group II and III was
delayed (P < 0.05) and blunted (P < 0.05) compared to Group I, and in
Group IV was shortened (P < 0.05) compared to Group III and blunted
(P < 0.05) compared to Group I, II, and III. In Group IV serum FT4 (1.26
0.21 ng/dl) was improved (P < 0.001), but serum T3 (109.2 37.1 ng/dl)
and FT3 (2.57 1.21 pg/mI) were not different from Group II and III. In
Group III serum BUN and creatinine correlated negatively with serum
FT4 (P < 0.001), and duration of hemodialysis correlated negatively with
serum FT4 (P < 0.05) and positively with serum T3 and FT3 (P < 0.05). In
conclusion, thyroid dysfunction is observed in CRF patients with partial
recovery after transplantation. Degree of azotemia and duration of
hemodialysis seem to be important factors of thyroid dysfunction in
patients with CRF.
The effect of immunological alterations induced by donor specific
transfusion on the transplanted kidney treated with cyclosporine A. H.
Rim, N.W Park, S.K Ji, H.M. Choi, YW Kim, LW Lee, S.H. Yang J.W
Lee, and S.D. Lee, Department of Internal Medicine and Department of
General Surgery, College of Medicine, Kosin University, Pusan, Korea. Donor
specific transfusion (DST) prior to kidney transplantation has been widely
accepted due to its beneficial effect on graft survival. The mechanisms of
the protective effect of DST are not clearly understood, although several
hypotheses have been suggested, including alterations of cell mediated
immunity. The significance of DST, however, tends to be decreased
following introduction of cyclosporine. Therefore, we investigated the
prognostic effect of mixed lymphocyte culture (MLC) and other cell
mediated immunological changes induced by DST. Ninety-eight HLA-
haploidentical renal transplants performed during the period of 1985
through 1991 were evaluated. Among these, 48 cases were the DST group
and the remainder were the control group. Immunological indices includ-
ing MLC were examined and graft survivals were analyzed. Graft loss was
defined as a loss of its function requiring dialysis. Following DST, the
stimulation index of MLC was significantly suppressed from 4.0 0.4
(mean SE) to 2.6 0.1 (P < 0.05). The relative response appeared to be
decreased after DST from 61.1 6.0% to 49.9 3.1%, although the
difference was not statistically significant. No significant changes in CD3,
CD4, CD8, DR cell, T-ceIl stimulation test by PHA and spontaneous
lymphocyte transformation were found after DST. For all indices there
was no significant difference between the postDST and control groups.
The actuarial graft survival rates for I and 5 years were 94 4% and 75
7%, respectively, in the DST group and 90 4% and 69 14%,
respectively, in the control group. The graft survivals of DST and control
groups were not significantly different. The 1- and 5-year graft survival
rates were 94 4% and 71 8%, respectively, in the DST group with the
SI value over 2.0, and 92 7% and 85 10%, respectively, in the DST
group with the SI value less than 2.0. The 1- and 5-year graft survival rates
were 91 5% and 72 8%, respectively, in the DST group with RR value
greater than 40%, and 100% and 85 10%, respectively, in the DST
group with RR value less than 40%. These results suggest that although
DST suppresses stimulation index, it could not improve graft survival in
HLA-haploidentical renal transplants treated with cyclosporine.
Effect of thromboxane synthetase inhibitor in cyclosporine nephrotox.
icity. J.J. Lee, HG. Moon, YH. Park, and TH. Kim, Department of
Pediatrics, College of Medicine, Yeungnam University, Department of Pathol-
ogy, Taegu Hyosung-Catholic University, Taegu, Korea. Cyclosporine A
(CsA) is a potent immunosuppressive agent which is extremely effective in
suppressing the allograft rejection and the treatment of autoimmune
diseases and nephrotic syndrome. Unfortunately, its use is limited by
chronic, irreversible nephrotoxicity. Administration of CsA induces a
renal vasoconstriction accompanied by a reduction in renal blood flow. An
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alteration of the prostaglandin-thromboxane cascade may be involved in
vasoconstriction. We studied the role of thromboxane A2 in CsA nephro-
toxicity and the effect of a thromboxane synthetase inhibitor, OKY-046, to
reduce CsA nephrotoxicity. Administration of CsA 25 mg/kg/day for 28
days to Sprague-Dawley rats resulted in an increase of urinary thrombox-
ane B2 (ng/24 hr) compared with control (47.9 11.5 vs. 27.2 9.7, P <
0.05), decreased Cr (ml/min/100 g; 0.25 0.07vs. 0.43 0.17, P < 0.01),
decreased FEK (%) (33.8 11.9 vs. 53.4 12.7, P < 0.05) and increased
serum potassium (mEq/liter) (5.5 0.5 vs. 4.8 0.4, P < 0.05), while
serum creatinine, sodium and FENa remained unchanged. Histologically,
cytoplasmic vacuolization in proximal tubular epithelial cells in light
microscopic examination and increased number of secondary lysosomes by
electron microscopic examination were major changes. Interstitial fibrosis
was not distinctive. In contrast, coadministration of OKY-046 with CsA
prevented the rise in urinary thromboxane B2 excretion (40.0 11.8 ng/24
hr), improved Cr (0.44 0.11 ml/min/100 g) and restored FEK (44.9
6.5%) to control levels. Histologic changes were also improved, such as
disappearance of cytoplasmic vacuolization and decreased number of
secondary lysosomes. These data indicate that CsA nephrotoxicity was
induced by increased thromboxane production and selective inhibition of
thromboxane production through TSI, OKY-046 may therefore be valu-
able in attenuating the nephrotoxicity of CsA.
The effect of thyroxine on cyclosporine A-induced hyperkalemia and
renal Na,K-ATPase activities in rats. E.S. Lee, SM. Shin, YH. Park,
and YJ. Kim, Department of Pediatrics, College of Medicine, Yeungnam
University, Department of Pathology, Taegu Hyosung-Catholic University,
Taegu, Korea. Hyperkalemia is a common complication of cyclosporine A
(CsA) therapy and may be induced by hypoaldosteronism or reduced
kaliuresis. The present study tests the hypothesis that thyroxine has a
protective effect on tubular injury by enhancing Na',K-ATPase activity
in rcnal cortex during CsA treatment. Serum potassium and creatinine,
FENa, creatinine clearance, CsA blood level and Na,K-ATPase activity
in the microsomal fraction of renal cortex were measured in 26 Sprague-
Dawley rats divided into 4 groups. Measurement of Na,KtATPase was
performed using a cytochemical method. Seven CsA treated rats (CT) and
7 nontreated rats (T) were pretreated with thyroxine (2.5 ,ag/100 g of body
wt/dose s.c.), 7 additional CsA treated rats received CsA only (C), and 5
rats which received normal saline (N) served as controls. CsA was
administered 25 mg/kg body wt intraperitoneally daily for 30 days.
Thyroxine was given to rats every day from 5 days before CsA adminis-
tration. Na',K-ATPase activity (rmol Pi/mg protein/hr) was decreased
in C group (17.6 4.8) compared with N group (36.8 6.9) and CT group
(29.3 4.9; P < 0.05). These activity alterations were correlated with
enzyme histochemical study for Na,K-ATPase activity on frozen sec-
tions of kidneys from experimental groups. Serum creatinine (mg/dl) was
increased insignificantly in C group (1.0 0.3) compared with N group
(0.7 0.2) and CT group (0.6 0.3). Creatinine clearance (liter/mg day)
was decreased significantly in C group (3.8 1.1) compared with N group
(6.2 2.4) and CT group (5.4 2.0; P < 0.05). Serum potassium
(mEq/liter) and FEK (%) were changed significantly in C group (5.4 0.5,
40.2 12.3) compared with N group (4.8 0.4, 59.5 15.5) (P < 0.05).
However, these were unchanged in CT group (4.5 0.5, 47.2 8.3) and
T group (4.4 0.3, 69.4 20.4). These results suggest that hyperkalemia
and reduced kaliuresis may be induced by reduction of renal cortical
Na,K-ATPase activity, and protected partially by concomitant admin-
istration of thyroxine which enhances renal cortical Na,K-ATPase
activity.
Expression of Na/K-ATPase using immunohistochemistry and in situ
hybridization in cyclosporine-treated rats. C. W. Yang, S.H. Lee, YS. Kim,
J.H. Cha, K. Y Ahn, J. Kim, and B.K Bang, Department of Internal Medicine
and Anatomy, Catholic University Medical College, Seoul, and Department
of Anatomy, Chun-Nam University Medical College, Kwang-Ju, Korea. This
study was designed to demonstrate the influence of cyclosporine (CsA) on
Na/K-ATPase expression and its effect on renal potassium handling.
The study groups were the control group (vehicle-treated, N = 6) and CsA
group (C5A 50 mg/kg for 7 days, N = 6). The results were as follows: (1)
Serum potassium levels in the CsA group were significantly higher than in
the control group (5.3 0.5 vs. 4.7 0.2 mEq/liter, P = 0.02) and
fractional potassium excretion in the CsA group was significantly lower
than in the control group (7.5 1.1 vs. 10.1 1.3, P < 0.01); (2) Plasma
renin activity increased significantly in CsA group (6.79 2.10 vs. 3.28
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1.16 ng/ml/hr, P = 0.02); (3) Immunohistochemistry and in situ hybridiza-
tion of Na/K-ATPase revealed decreased Na/K-ATPase expression
in the CsA group compared to the control group. In conclusion, CsA
suppresses Na]K'-ATPase expression, and this finding seems to be
related with clinical hyperkalemia.
Renal lesion in multiple myeloma. J. Suk, I. Joo, SB. Park, and H.C.
Kim, Department of Internal Medicine, Keimyung University School of
Medicine, Taegu, Korea. Renal involvement in multiple myeloma occurs in
approximately 50% of patients. The renal involvement in multiple my-
eloma has variable features: proteinuria, nephrotic syndrome, amyloid-
osis, renal tubular dysfunction, recurrent urinary tract infection, acute and
chronic failure. We retrospectively analyzed the clinical manifestation
courses and prognosis in 14 of 46 patients who had multiple myeloma with
renal involvement at Keimyung University Dong San Hospital. The results
were as follows: There were eight male and six female patients and their
ages ranged from 36 to 72 years with a mean age of 54.6 11.5 years. The
patterns of renal lesion were acute renal failure in 7 (50%) and chronic
renal failure in 7 (50%) at the time of diagnosis. In the renal involvement
group, blood urea nitrogen, serum creatinine, serum calcium and 24 hour
urine protein were significantly elevated from the non-involvement group.
Among 14 patients with renal involvement, we biopsied 7 patients, and the
pathologic diagnoses were established myeloma kidney in 4 patients,
hypercalcemic nephropathy in 2, and light chain nephropathy in 1. The
renal function completely recovered in 7 patients with acute renal failure
and improved clinically in 7 patients with chronic renal failure with renal
replacement treatment. An azotemic group in multiple myeloma had a
significantly shorter median survival than the non-renal involvement group
(8 vs. 29 months). These findings suggest that renal involvement in
multiple myeloma is considered to be one of the major prognostic factors.
Effects of mixed lymphocyte culture supernatant (MLCS) and cyclo-
sporine A (C5A) on the expression of cell adhesion molecules on mesan-
gial (M) and endothelial cells (E). C.G. Ihm, J.K Park, J.H. Ahn, T W. Lee,
and Mi. Kim, Department of Internal Medicine, College of Medicine,
KyungHee University, Seoul, Korea. VCAM-1 and /31 integrins mediate the
cell-cell or cell-matrix interaction. VCAM-1 expression has been reported
in rejections and autoimmune nephritis, but the expression of /31 integrins
or the additional effects of CsA remain undefined. We investigated the
effects of MLCS and CsA on their expression on M and E by cell ELISA
and FACS. After 24 hours, VCAM-1 expression on M was increased by
LPS, TGF-/31 and IFN-y, and a3/31 and a5131 integrin on M and E were
increased by TGF/31 and IFNy. CsA didn't increase the expression of
VCAM-1, a3/31 and cs5j31 on M or E. CsA reduced the increase induced
by LPS or TGF/31. MLCS with or without IFNy and hydrocortisone
increased the expression of VCAM-1 on M and E by above 28%. CsA
pretreatment reduced MLC-induced increase in the VCAM-1 expression
on M and E. In conclusion, CsA does not increase the expression of
VCAM-1, a3/31 and a5/31, but reduces the increase induced by LPS and
TGFj31. MLCS induces the increase in VCAM-1 expression on M and E,
which is suppressed by CsA. Further study is necessary to investigate the
long-term effects of CsA.
Effect of dopamine and furosemide in oliguric renal failure of hemor-
rhagic fever with renal syndrome. J.H. Song, ES. Kim, J.S. Bang, YJ. Kim,
and M.J. Kim, Department of Internal Medicine, College of Medicine, Inha
University, Incheon, Korea. High-dose furosemide is known to decrease the
oliguric period and minimize the need for dialysis in acute renal failure
(ARF) patients by inducing diuretic response. Dopamine has been also
used in oliguric ARF for it's effect of decreasing renal vascular resistance
and improving cortical vasculature. In the study, all patients showed
oliguria and were administered with high-dose furosemide (20 mg/hour)
and low-dose dopamine (2 jg/kg/min) within 12—24 hours after develop-
ment of oliguria in acute renal failure of hemorrhagic fever with renal
syndrome. There were 26 patients total: 14 control (mean age 42 16)
and 12 treatment patients (43 9). There were no significant differences
in BUN levels at onset of oliguria, peak and recovery between both
groups. Creatinine (Cr) level at peak showed significant difference be-
tween the treatment (5.1 1.9 mg/dl) and control groups (7.3 2.6) (P <
0.05).There were no significant differences in Cr levels at onset of oliguria
and the recovery period between the two groups. The mean oliguric period
in the treatment group was 3.0 1.8 days, which differed significantly from
5.7 3.0 days in the control group (P < 0.05). The duration from the day
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of oliguria development to peak Cr level was 3.2 1.5 days in the
treatment group, which differed significantly from 4.4 1.1 days in the
control group (P < 0.05). There were no significant differences in duration
from peak Cr day to recovery day between both groups. The total duration
ofARFwas 9.5 6.3 days in the treatment group and 11.3 5.4 days in
the control group without any differences between the two groups. There
were no deaths in both groups and dialysis was needed in 4 of the
treatment patients (1 HD, 3 APD) and in 7 of the control patients (3 HD,
4 APD). As a result, the combination of dopamine and furosemide at the
early stage of oliguric renal failure is helpful in decreasing the oliguric
period and the need for dialysis in hemorrhagic fever with renal syndrome.
Acute renal failure (ARE) associated with yersinia pseudotuberculosis
(YP) infection. J. W Koo, C. Y Chung, H. W. Park, Hi. Cheong, and Y Cho4
Department of Pediatrics, College of Medicine, Inje University, Sanggye Paik
Hospital, Seoul City Borame Hospital, and Seoul National University, Seoul,
Korea. YP can cause a wide range of clinical problems, such as mesenteric
lymphadenitis, erythema nodosum, reactive arthritis, and sepsis. ARF
associated with a YP infection began to be reported starting in 1981 in
Japan. We have experienced 70 children with YP infection diagnosed from
stool culture and/or serology since 1987. A history of drinking untreated
mountain water was detected in 67 cases; YP was also isolated from 5
samples of mountain water which was thought to be the source of the YP
infection. The most prevalent serotypes were 5 (33/70) and 4 (25/70). ARF
developed in 18 cases (25.7%) during the course of illness. The disease
began with a sudden onset of fever, rash, and abdominal pain mimicking
acute appendicitis. Periungual desquamation developed later in the
course. Thrombocytosis and hypoalbuminemia were noticeable, and mild
degrees of proteinuria, microscopic hematuria, and pyuria were common
in the ARF group. ARF developed between the 2nd and 17th days after
the onset of fever. Oliguria developed in 12 cases immediately after fever
had subsided. ARF underwent a benign course with complete recovery
within 4 weeks. One case required hemodialysis. The renal biopsies mainly
revealed findings of acute interstitial nephritis (AIN). YP should be
included as one of the causes of AIN causing ARF in children, especially
with the history of drinking untreated water in endemic areas.
Underlying mechanisms of reduced glucose reabsorption in rabbits
with nonoliguric ischemic acute renal failure. YK Kim, YH. Kim, J.S.
Woo, iS. Jung, and S.H. Lee, Department of Physiology, College of Medicine,
Pusan National University, Pusan, Korea. This study was undertaken to
investigate the mechanisms by which renal ischemia causes a reduction in
glucose reabsorption by renal proximal tubules. Unilateral ischemia was
induced by clamping the left renal artery, and the right kidney served as a
paired control. Isehemia of 30 or 60 minutes induced a significant increase
in the excretion of glucose and phosphate, which did not return to the
control values even 180 minutes of reperfusion. The uptake of glucose and
phosphate was not altered in brush-border membrane vesicles (BBMV)
and basolateral membrane vesicles (BLMV) isolated from kidneys sub-
jected to ischemia for 60 minutes. However, tetraethylammonium
(TEA)/H antiport by BBMV was significantly impaired after 30 minutes
of ischemia. The functional Na'-pump activity (estimated by ouabain-
sensitive oxygen consumption) in renal cortical slices remained unaltered
after 60 minutes of ischemia. When kidneys were reperfused for 60
minutes after ischemia (60 minutes), the glucose uptake and TEA1H
antiport by BBMV were not different from those of the controls. Tissue
oxygen consumption and microsomal Na-K-ATPase activity also re-
mained unchanged in kidneys reperfused for 60 minutes after 60 minutes
of isehemia. When ischemia was prolonged to 120 minutes, oxygen
consumption was significantly reduced, but it returned to the control value
by reperfusion for 60 minutes. Electron microscopic evaluation showed a
focal loss of microvillus brush-border in kidneys subjected to ischemia for
60 minutes, which were partially regenerated when kidneys were reper-
fused for 180 minutes. These results indicate that glucosuria by a transient
ischemia is, at least in part, due to diminution of surface area for
reabsorption by a substantial loss of brush border rather than a direct
impairment of the membrane transport system or an inhibition of Na'-
pump activity in rabbit proximal tubules. Furthermore, the data suggest
that proximal tubular function is not progressively deteriorated by reper-
fusion after ischemia in nonoliguric ischemic acute renal failure.
Clinical analysis about APACHE HI score in acute renal failure. J.S.
Song, SM. Ohh, K.H. Lee, K. T. Cheon, J.J. Nam, KS. Park, and 5K. Kang,
Department of internal Medicine, Chonbuk National University Medical
School, Chonju, Korea. We studied APACHE III score in order to identify
prognostic risk factors influencing survival and to predict the mortality in
ARF patients. ARF was diagnosed when glomerular filtration rate was
acutely reduced to more than 50% of normal renal function or serum
creatinine level increased above 2 mg/dl in people with normal renal
function. Data collection began in January 1991 and was completed by
December 1994. We retrospectively analyzed 105 patients with ARF. For
each patient, we collected the patient's vital signs and laboratory tests
upon time of admission. This information was then transformed into an
APACHE III score consisting of an admission Acute Physiology Score
(pulse, mean BP, temperature, respiration rate, Pa02, A-aDO2, acid-base
disturbance, hematocrit, WBC, creatinine, creatinine clearance, urine
output, BUN, sodium, albumin, bilirubin, glucose), Age, and Chronic
Health Evaluation. Statistical significance was analyzed using Student's
t-test for paired data in survivors and non-survivors. P < 0.05 was accepted
as statistically significant. Of the 105 patients, there were 68 survivors
(64.8%) and 37 nonsurvivors (35.2%). APACHE III scores were the
significant differences between survivors and nonsurvivors (P < 0.0001).
Clinical characteristics of acute renal failure (ARF) in the nephrotic
syndrome (NS). KS. Yoon, T W. Lee, C.G. ibm, and Mi. Kim, Department
of Internal Medicine, College of Medicine, KyungHee University, Seoul,
Korea. The clinical characteristics of the nephrotic patients who did or did
not develop ARF are not well defined. Therefore, we analyzed clinical
characteristics of the 111 nephrotic patients (MCD 26; MGN 45; MPGN
type I 6; FSGS 11; IgA N 20; and mesangial proliferative GN 2) who
developed ARF or did not develop ARF and acquired the following
results. ARF developed in 11 (MCD 2; MGN 2; MPGN type II; FSGS 2;
IgAN 3; mesangial proliferative GN 1) of 111 nephrotic patients and the
clinical characteristics of the nephrotic patients with (ARF) or without
ARF (NARF) were as follows: (1) Age and sex distribution was not
different between the two groups. (2) Male to female ratio was 7:4 in the
ARF group and 74:26 in the NARF group. (3) The blood pressure was not
different between the two groups. (4) The initial serum albumin concen-
tration and the 24 hour urinary protein excretion in the ARF group were
not different from those in the NARF group. In the therapeutic response
to the treatment with steroid and/or cytotoxic agents, 2 of 11 ARF patients
failed to recover and the clinical characteristics of patients who recovered
(ARF-R) or not (ARF-NR) were as follows: (1) The age and sex
distribution was not different between the two groups. (2) The male to
female ratio was 6:3 in the ARF-R group and 1:1 in the ARF-NR group.
(3) The blood pressure was not different between the two groups. (4) The
initial serum albumin concentration, the 24 hour urinary protein excretion,
and serum creatinine were not different between the two groups. (5)
ARF-R group recovered at 5.9 (2—14) weeks, 24 hour proteinuria of
ARF-R group was 13.7 glday at admission and 3.7 g/day at recovery (P <
0.01), but the ARF-NR group was 10.3 g/day at admission and 16.0 g/day
at 6 weeks after admission. However, differences in the reduction of
proteinuria according to the underlying diseases were not discovered.
Oliguria was detected in 1 of ARF-NR (FSGS), but not in the others.
Daily urine volume of the ARF-R group was not changed before and after
therapy of ARF. Conclusively, the clinical characteristics of ARF in
nephrotic syndrome were not specific, but degree of therapeutic respon-
siveness of proteinuria may he associated with recovery of ARF.
Clinical study of acute renal failure. S.S. Lim, J.P. Kim, T W. Lee, C.G.
ibm, and M.J. Kim, Department of Internal Medicine, College of Medicine,
Kyung Hee University, Seoul, Korea. Acute renal failure (ARF) is a clinical
syndrome characterized by a sudden decrease in renal function which was
previously normal. Despite advances in medical care, prognosis in ARF is
variable according to the influence of demographic factors, severity of
ARF, nature of disease causing ARF, coexisting disease, treatments
received, and complications. To determine the recent changes of clinical
features of ARF, the authors retrospectively reviewed 245 patients with
ARF who had been hospitalized at Kyung Hee University Hospital
between February 1988 and March 1993. The findings are as follows: (1)
The male to female sex ratio was 1.8:1, and the incidence was high in ages
above fourth decade (67.8%). (2) Acute renal failure was classified,
according to clinical background, into medical group 79.6% (195 cases),
surgical group 20.4% (50 cases), oliguric group 40.8% (100 cases), and
non-oliguric group 59.2% (145 cases). (3) Acute renal failure due to
medical causes included hemorrhagic fever with renal syndrome (25.6%),
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drugs and chemicals (17.9%), sepsis (17.4%) and systemic infection
(7.7%), etc. ARF due to surgical causes included multiple trauma (34%),
ARF developing after various surgical procedure (30%), surgical sepsis(14%), burn (12%), etc. (4) Infections as the cause of ARF included 107
cases (43.7%), which included hemorrhagic fever with renal syndrome 50
cases, sepsis 31 cases, urinary tract infection 7 cases, and respiratory tract
infection 6 cases, etc. The most common infecting organism was Hanta
virus (50.5%). There was a greater number of gram-negative organisms
than gram-positive organisms (34.1% vs. 9.9%). (5) The overall mortality
rate in patients with ARF was 31.4%. The presumptive causes of death
were underlying disease (59.7%) such as sepsis, acute poisoning, cardio-
genie and hypovolemic shock, and respiratory failure (14.3%), hyperkale-
mia (9.1%), pulmonary edema (6.5%) and metabolic acidosis (2.6%), in
order of frequency. (6) The highest mortality rate was 42.6% in patients
above 50 years old. Mortality rates in patients with ARF due to surgical
causes (52.0%) were significantly high than that of medical causes (26.2%;
P < 0.05). Among the patients with death, oliguric group was 72.7%. (7)
During admission, the patients with death had a more severe biochemical
and clinical characteristics including high BUN and serum potassium (P <
0.01), lower serum albumin (P < 0.01), and shorter duration of hospital-
ization (P < 0.05) than those of survivors. In conclusion, there have been
major trends in the clinical features of acute renal failure in this study.
There were especially, significant increases in the number of elderly
patients, non-oliguric patients, and medical causes such as hemorrhagic
fever with renal syndrome or sepsis observed. Survival significantly
decreased with increasing.
Clinical characteristics of deaths from acute renal failure. KY. Na, Y. K.
Oh, YS. Cho, YS. Kim, Hf. Yoon, C. Ahn, iS. Han, S. Kim, andf.S. Lee,
Department of Internal Medicine, College of Medicine, Seoul National
University, Seoul, Korea. Even with remarkable advances in the treatment
of ARF, including newly developed techniques in dialysis, it has been
known that the mortality of ARF has not been changed. The reasons for
this persistently high mortality have been thought to be that there was no
consistent clinical index which can reflect the diverse clinical courses. To
evaluate the possible prognostic factors including mortality, we analyzed
419 ARF patients from a single center. Among 419 patients referred to the
Division of Nephrology, Seoul National University Hospital from 1990 to
1994 and diagnosed to have ARF, 69 patients had died. The clinical
characteristics of these 69 cases were as follows: The expired were older
than the survivors (median age: 49 vs. 43, P < 0.05). Male (42 cases) to
female (27 cases) sex ratio was 1.5:1. Prerenal ARF was 9% (6/69). Renal
ARF was 84% (58/69) and consisted of ischemic acute tubular necrosis
(ATN) 51% (35/69), toxic ATN 14% (10/69), glomerular diseases 6%
(4/69), renal vascular obstruction 4% (3/69), hemorrhagic fever with renal
syndromes 4% (3/69), and others 4% (3/69). Postrenal ARF occupied 7%
(5/69). Comparing the two groups, ischemic ATN was more common in
the expired group (51% vs. 17%, P < 0.05). Oliguric ARF was more
common in the expired group (78% vs. 51%, P < 0.05). Dialysis therapy
was performed more commonly in the expired group (64% vs. 21%, P <
0.05) including hemodialysis in 31 cases, peritoneal dialysis in 2 cases, and
continuous arteriovenous hemofiltration in 6 cases. Dialysis indications
were volume control or daily increasing creatinine (37 cases), hyperkale-
mia (4 cases), and uremia (3 cases). No significant differences were
observed in the duration of oliguria (median duration of oliguria: 14.3
days vs. 10.7 days) and in the initial serum creatinine levels (mean value:
3.9 mg/dl vs. 4.1 mg/dl). The causes of death were infection 43% (30/69),
underlying disease 28% (19/69), respiratory complications 13% (9/69),
neurologic complications 7% (5/69), cardiovascular complications 6%
(4/69), and the unknown causes were 3% (2/69). APACHE II scores in the
69 expired patients were from 8 points to 34 points (median points: 18.6)
but the interpretation of those values were impossible due to no available
data on the survivors. In summary, ischemic ATN was the most common
cause of ARF in the expired patients. The major cause of death was
infection. Old age, oliguric ARF and the dialysis requirement were the
poor prognostic factors.
Clinical observation of acute renal failure treated with dialysis. W.K
Chung, KW Oh, YS. Cho, YS. Kim, H.J. Yoon, C. Ahn, IS. Han, S. Kim,
and J.S. Lee, Department of Internal Medicine, College of Medicine, Seoul
National University, Department of Internal Medicine, Boramae City Hospi-
tal, Seoul, Korea. Multiple factors still influence the high rate of mortality
in acute renal failure. Clinical observations were performed in search of
prognostic indicators in 132 cases of acute renal failure who had been
admitted to Seoul National University Hospital from January 1990 to
December 1994 and referred for dialysis. The following results were
obtained: the incidence rate was highest in the sixth and seventh decades,
the number of patients older than sixty was 31, and male to female ratio
was 1.6:1. The major precipitating causes were toxic acute tubular necrosis
(39 cases), isehemic ATN (36 cases), hemorrhagic fever with renal
syndrome (19 cases), and glomerular diseases (16 cases). The incidence of
oliguric ARF was 89.3% (117/132) and duration of oliguria was 10 days
(2—60 days, median, range). Dialysis was performed in 109 patients for
progressive azotemia or hypervolemia, 16 cases of uremic symptoms, and
7 cases of hyperkalemia. The median frequency of dialysis was 4 cycles
(1—25). The mortality of our series was 34.6% (45/1 30), and at the time of
discharge serum creatinine was below 1.5 mg/dl in 64.7% of the survivors.
The causes of death were infection in 22 cases, underlying diseases in 13
cases, respiratory complications in 5 cases, neurologic complications in 2
cases, acute myocardial infarction 1 case, gastrointestinal bleeding in 1
case, unknown causes in 2 cases. The mortality according to etiologic
factors, prognosis of ischemic ATN was poorer than others (66.7% vs.
24.0%, P < 0.05), and the change of consciousness level was a poor
prognostic sign (54.1% vs. 30.2%). When compared with APACHE II
score in acute renal failure (except prerenal and postrenal cause) total
score (17.8 vs. 14.3) (mean) and chronic health point (2.74 vs. 1.07) were
higher than survivors than in non-survivors (P < 0.05). In summary, toxic
ATN was the most common cause of ARF treated with dialysis and
ischemic ATN, and neurologic abnormality showed poor prognosis. We
should pay closer attention to ARF with chronic disorders and to the
prevention of infection.
Causes of acute renal failure. W.S. An, H.C. Kwon, SE. Kim, and KH.
Kim, Department of Internal Medicine, Dong-A University, Pusan, Korea.
The cause of ARF is variable and the prognosis is very different according
to the various causes or treatment modalities. We studied precipitating
factors, causes, and death rate of ARF. We reviewed the medical records
of ARF cases treated retrospectively from May 1990 to December 1994.
The results are as follows: (1) The prevalence in males was more common
than in females (M:F = 2.4:1) and the larger age group was those over 60
years old (56 cases, 42.4%). (2) Prerenal cause was the most frequent in 94
cases (71.8%), and renal cause was seen in 25 cases (19.1%), and postrenal
cause in 12 cases (9.1%). (3) Among the eases of prerenal causes,
hypovolemia was the most frequent, with 52 cases (55.3%), decreased
effective plasma volume was seen in 28 cases (29.8%), decreased cardiac
output in 13 cases (13.8%), and renovascular obstruction in one case
(1.1%). (4) Causes of hypovolemia (52 cases) were dehydration in 20 cases(38.5%), hypoalbuminemia in 11 cases (21.2%), trauma in 9 cases
(17.3%), and surgery in 6 cases (11.5%). (5) Sepsis was the most frequent
cause of decreased effective plasma volume, in 23 cases (82.1%), and
hepatobiliary tract infection was seen in 7 cases (30%), and respiratory
system infection in 6 cases (26%). (6) Renal causes (25 cases) could be
seen in 8 cases (32%) of toxic nephropathy and 7 cases (28%) of pigment
nephropathy. (7) Stones were the most frequent among postrenal cause, in
6 (50%) out of a total of 12 cases. (8) The patients with underlying
diabetes mellitus (DM) were 16 (12.2%) cases in the prerenal ARF group,
and those with preexisting hypertension (HTN) were 9 (6.95%) cases. (9)
The overall death rate was 43.5% (57 cases) and that of those with
prerenal causes were 46%, renal causes 44%, and postrenal causes 25%.
Death rate was higher in cases with cardiovascular diseases and sepsis,
with 69.2% (9/13 cases) and 43.5% (10/23 cases), respectively. Prerenal
ARF was most frequent and the overall death rate was high in spite of the
use of dialysis for management. We concluded that old age, DM, and HT
comprised the important predisposing factor and thus patients with these
conditions should be watched carefully to prevent the relatively frequent
development of ARF.
Acute renal failure in patients with acute pancreatitis. Yf. Kim, ES.
Hong, J.S. Bang, IH. Song, and M.J. Kim, Department of Internal Medicine,
College of Medicine, Inha University, Incheon, Korea. Acute renal failure
(ARF) is considered to be an important and frequent problem in acute
pancreatitis. Risk factors such as age, pre-existing chronic disease, sys-
temic infection, and organ systemic failure are proven predictors of ARF
development and outcome. We analyzed the prevalence, clinical charac-
teristics and risk factors of patients with ARF in acute pancreatitis, all of
whom had been admitted to Inha University Hospital between January
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1986 and December 1994. ARF developed in 20 (6.6%) of total of 305
patients with acute pancreatitis. Seventeen of the patients were male, 3
were female, and the ratio was 5:7. The average age was 43.3 years old.
The peak serum amylase/lipase level was 458.7/1676.6 U/dl and BUN!
creatinine level was 6.2/4.7 mg/dl. The serum LDH and AST levels were
increased in 15 (88.2%) and 13 (76.5%) patients, respectively. There were
12 (64.7%) patients with hypoalbuminemia, 11(64.7%) with hyperurice-
mia, and 7 (41.2%) with hypocalcemia. The complications included shock
(7), pulmonary problems (7), gastrointestinal bleeding (3), DIC (1),
pancreatic ascite (8), and pseudocyst (1). Eleven (64.7%) patients were
given supportive care and peritoneal dialysis was performed in 6 (35.3%)
patients. The average duration of renal failure and length of hospital stay
were 5.9 days and 23.6 days in patients with supportive care, but 7.4 days
and 16.2 days in patients with peritoneal dialysis, respectively. Thirteen
patients were cured (76.5%) and 4 died during therapy. The mortality rate
of ARF in acute pancreatitis was 23.3%.
Renal biopsy in acute renal failure. I. Joo, J. Suk, SB. Park, and H.C.
Kim, Department of Internal Medicine, Keimyung University School of
Medicine, Taegu, Korea. We have performed percutaneous renal biopsies
on 30 patients with acute renal failure. Thirteen of the patients were male,
and 17 were female. The age ranged from 16 to 74 years, with a mean age
of 45.9 years. Indications for biopsy were classified into the following 5
categories: lack of precise etiology in 7 patients (23.7%), protracted
oligonuria in 6 (20%), extrarenal manifestation in 9 (30%), to exclude the
possibility of acute interstitial nephritis in 4 (13.3%), atypical renal signs
(proteinuria over 2 g/day, or hematuria) in 4 (13.3%). Clinical diagnoses
were grouped into S categories on the basis of clinical criteria: acute
tubulointerstitial renal disease (ATRD), 8 patients with acute glomerulo-
nephritic syndrome (AGN), 10 patients with acute glomerulonepritis in
systemic disease (AGSD), 8 patients with acute nephropathy in a chronic
disease, and 4 patients in each category. In the 7 of 8 patients with ATRD,
9 of 10 with AGN, 7 of 8 with AGSD, 3 of 4 in ANSD were correlated with
the clinical and histological diagnoses. Pathologic diagnoses of 30 acute
renal failure patients were as follows: crescentic glomerulonephritis in 7
cases (23.3%), acute interstitial nephritis in 4 cases (13.3%), post-
streptococcal glomerulonephritis in 4 cases (13.3%), acute tubular necro-
sis in 4 cases (13.3%), membranoproliferative glomerulonephritis 3 in
cases (10%), hemolytic uremic syndrome in 2 cases (6.7%), diffuse cortical
necrosis, Wegener's granulomatosis, lupus nephritis, multiple myeloma,
amyloidosis and IgA nephropathy 1 case (3.3%), respectively. No fatal or
toxic complication occurred, only microscopic hematuria 6 cases (20%),
gross hematuria in 3 cases (10%), and loin pain 1 case (3.3%). Our results
suggest that renal biopsy in selected cases of acute renal failure is very
useful in evaluating prognosis and in planning optimal treatment.
The eosinophil cationie protein (ECP) and soluble interleukin-2 recep-
tor (sIL-2R) in Henoch-Schonlein purpura (HSP) and IgA nephropathy
(IgAN). M.K Namgoong, B.K Lim, and iS. Kim, Department of Pediatrics,
Wonju College of Medicine, Yonsei University, Wonju, Korea. Mesangial
cells have the gene containing IL-6. IL-6 Secretes IL-2, IL-4 and IL-S from
T lymphocytes. IL-2 and IL-5 secrete major basic proteins and ECPs from
eosinophil in type I hypersensitivity and various skin diseases. HSP only
has the skin manifestation in mesangial proliferative disorders such as
HSP, IgAN and membranoproliferative glomerulonephritis. However, the
mechanism of skin manifestation in HSP remains unclear. We have
examined serum ECP and sIL-2R in HSP and in IgAN in order to detect
whether they would be one of the different pathogenetic mechanisms in
HSP and in IgAN. Soluble IL-2R (T-cell Diagnostics, USA) was measured
by ELISA. Serum ECP (Pharmacia, UK) was measured by RIA. Serum
total IgE was measured by PRIST. The levels of ECP in HSP, IgAN and
a control group were 13.1 12.4, 8.6 4.3, and 6.3 3.1 (g/liter),
respectively. The levels of sIL-2R in HSP, IgAN and the control group
were 1,110 417, 825 437, and 278 323 (jsg/liter), respectively.
However, there were significant increases of ECP and sIL-2R in HSP
among them. These results show that the eosinophil activation behaves
like one of the important pathogenetic mechanisms in HSP.
Renal expression of Iipocortin-1 (LC-1) and its receptor in various
forms of glomerulonephritis. SB. Kim, W.S. Yang, S. Park, E. Vu, D.S. Na,
J.S. Park, and CD. Hong, Department of Internal Medicine, Diagnostic
Pathology and Biochemistry, University of U/san, Seoul, Korea. LC-1, a
Ca tdependent phospholipid binding protein, is believed to be involved
in anti-inflammatory actions of glucocorticoids. To evaluate the relation-
ship between the expression of LC-1, its putative receptor and the
responsiveness to glucocorticoids in various forms of glomerulonephritis,
frozen samples of 7 normal kidneys and 30 renal biopsies were evaluated
with indirect immunofluorescent staining. In the normal tissues, minimal
change disease (N = 9) and IgA nephropathy (N = 6), glomeruli were not
stained for LC-1 nor its receptor. In membranous nephropathy (N = 8),
weak to strong reactions for LC-1 were observed along the peripheral
capillary walls in 6 patients. All 5 patients without HBsAg showed positive
reactions. Staining for LC-1 receptor was positive with similar patterns for
LC-1 in all of the 8 patients. Patients with membranoproliferative
glomerulonephritis (N = 2) showed positive reactions for both LC-1 and
its receptor along the capillary walls. In lupus nephritis (N = 5), only 1
patient showed weak immunofluorescence for LC-1 receptor, mainly in
the mesangial area. These results showed that expression of LC-1 or its
receptor might be somehow related to the clinical responsiveness to
glucocorticoids. This is the first study showing alterations in the expression
of LC-1 in various forms of glomerulonephritis.
A molecular genetic study on the pediatric patients with IgA nephrop.
athy or Henoch-Schbnlein nephritis: Complement 4 locus II gene deletion
and DQA1*0301 gene. D.K fin, J. W. Ku, IS. Ha, H.!. Cheong, and Y. Choi,
Department of Pediatrics, Samsung Medical Center, Department of Pediat-
rics, College of Medicine, Seoul National University, Seou4 Korea. There
have been several reports which suggest that the frequency of complement
4 (C4) protein deficiency is increased in the patients with IgA nephropathy
(IgAN) or Henoch-SchOnlein nephritis (HSN) compared to the general
population. As C4 gene is located on the short arm of chromosome 6 and
is near the major histocompatibility complex which plays an important role
in the immune response, we investigated the C4 allotype and structural
abnormality of C4 gene as well as DQA, DQB, and DRB allele. In the
current study, 49 Korean patients (IgAN:22, HSN:27) were enrolled and
included 105 normal volunteers as the control group. The allotyping of C4
was done by immunofixation, and DQB, DRB alleles were investigated by
Southern hybridization. DQA1 gene was subtyped by PCR-RFLP method,
and the following results were obtained: (1) There was no allotype
including the null allele (isotype deficiency) that was significantly in-
creased or decreased between patients and control groups. (2) In the TaqI
RFLP, there was increased frequency of locus II deletion of C4 gene in the
patient groups (18%) compared to control (3%), and in the N1aIV RFLP,
there were 3 cases of heterozygous A deletion, 1 case of homozygous B
deletion, and 5 cases of heterozygous B deletion. (3) There were no
significant differences in the frequency of C4 gene duplication, DQ allele,
or DR allele between the two groups. (4) There was increased frequency
of DQA1*0301 in the IgAN group (rr = 4). These results suggest that
DQA1*0301 as well as C4 gene deletion could be genetic risk factors for
the diseases in Korean children.
The influences of pregnancy on the renal function and fetal outcome in
women with underlying primary renal disease. VS. Shin, S.H. Lee, C. W.
Yang, YS. Kim, S. Y Kim, W.S. Koo, YS. Yoon, and B.K Bang, Department
of Internal Medicine, Catholic University Medical College, Seoul, Korea. The
influences of pregnancy on the renal function and fetal outcome in women
with underlying primary renal disease were studied retrospectively. The
clinical courses of 28 women who underwent 39 pregnancies from 1980
through 1994, whose underlying primary renal diseases were analyzed (Ig
A nephropathy 13 cases; FSGS 4 cases; minimal change GN 2 cases;
membranous GN 1 case; MPGN 1 case; others 8 cases; CRF with dialysis
3 cases). The influences of preconception renal function on underlying
primary renal disease and the result of pregnancy were followed. In 29
pregnancies with normal renal function (Cr < 1.4 mg/dl), the number of
cases of deteriorated renal function was 1 and fetal loss 3. In pregnancies
with moderate (1.4  Cr < 2.8) and severe (Cr  2.8) renal dysfunction,
all renal function was deteriorated. Fetal losses were 1 in mild and 3 in
moderate cases. The effects of preconceptional blood pressure on the
renal function and fetal losses were followed. In hypertensive cases (BP 
140/90), the cases of deteriorated renal function were 9 and fetal loss 9. In
normotension, fetal losses developed in 2 cases. These pregnancies
resulted in 20 normal deliveries, 8 preterm deliveries and 8 fetal losses. It
is concluded that, in women with moderate renal insufficiency and
hypertension, pregnancy is accompanied by decline in renal function and
poor fetal outcome.
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Clinical features and management of minimal change nephrotic syn-
drome with liEs antigenemia. 5G. Lee, U.S. Jun, VS. Kim, C. Ahn, J.S.
Han, S. Kim, J. S. Lee, and H. S. Lee, Department of Internal Medicine and
Pathology, Seoul National University College of Medicine, Seou4 Korea.
Minimal change nephrotic syndrome (MCNS) is one of the most common
causes of adult primary nephrotic syndrome and responds well to corti-
costeroids or cytotoxic agents. The prevalence of HBs antigenemia of
MCNS is 5—10% in Korea, the same as in the general population, but it is
not known whether MCNS with HBs antigenemia has different clinical
features than that of MCNS without antigenemia. We studied clinical
features of MCNS with HBs antigenemia and impairment of liver function
associated with corticosteroid or cytotoxic treatment to assess the influ-
ence of HBs Ag in the clinical features of MCNS. Twenty-one MCNS
patients with HBs antigenemia (HBV-MC) who visited Seoul National
University Hospital during 1979—1994 were compared with 25 MCNS
patients without evidence of HB viral infection (MC). The age of
HBV-MC patients was 28 years (17—54 median, range), and males
outnumbered females (16:5), and this was similar to MC patients.
Twenty-four hour urine protein and serum cholesterol levels posed no
difference, but HBV-MC patients had higher serum albumin and serum
IgG levels [2.3 0.15 g/dl vs. 1.8 0.08 (mean se), 600 94.7 mg/dl
vs. 337 60 (median SE); P < 0.05] than MC patients. The positive rate
of RA factor, cryoglobulin and ANA had no differences between these two
groups. Cumulative remission induction rates in patients who received
steroid or cytotoxic treatment were 13/14 in 8 weeks, 14/14 in 16 weeks
(HBV-MC patients), 18/21 in 8 weeks, 19/21 in 16 weeks (MC patients),
and no differences were found. Relapse rates were 1/11 in 16 weeks, 2/9 in
25 weeks (HBV-MC patients), 1/16 in 16 weeks, 1/15 in 25 weeks (MC
patients), and no differences were found. Serum AST/ALT levels were
increased more than 4 times in 2 of the HBV-MC patients. One of these
two patients had positive seroconversion of HBe antigen, and the other
was diagnosed as liver cirrhosis by liver biopsy. We concluded that HBs
antigenemia does not have a significant effect on the clinical features of
MCNS, and steroid or cytotoxic agents can be used safely in MCNS with
HBs antigenemia.
Analysis of renal biopsy in the elderly. K T Bin, J.S. Kim, S.M. Oh, S.S.
Kim, K W. Lee, J.H. Lee, KS. Seo, and Y T. Shin, Department of Internal
Medicine, Department of Pathology, College of Medicine, Chungnam Na-
tional University Hospital, Taejon, and Department of Internal Medicine,
College of Medicine, Dungguk University, Hospital, Kwongju, Korea. To
evaluate the clinical significance of renal biopsy, renal biopsies were
performed in 30 patients (aged 60 years or older) at the Department of
Internal Medicine from 1986 to February 1995. The male to female ratio
was 1:1, and the average age was 65 years. Clinical manifestations of
patients were nephrotic syndrome (56.7%), acute renal failure (23.3%),
asymptomatic urinary abnormality (10%), and glomerulonephritis com-
bined with systemic disease (10%). The results of the renal biopsy were:
primary glomerular diseases in 20 patients (66.7%); IgA nephropathy in 5;
membranous nephropathy in 5, focal and segmental glomeruloscierosis
(FSGS) in 4; minimal change disease in 3; diffuse glomerulosclerosis in 2;
and diffuse proliferative glomerulonephritis in 1. Six patients showed
secondary glomerular diseases: amyloidosis (3); diabetic nephropathy (1);
Henoch-Schönlein purpuric nephritis (1); and hepatitis B virus associated
glomerulonephritis (1). Four patients (13.3%) showed acute interstitial
nephritis. Seven patients with primary glomerular disease induced ne-
phrotic syndrome were treated with steroids and/or immunosuppressive
agents over 6 months. Four of them recovered completely. Among these
4 patients, the renal pathology of 2 patients was membranous nephropathy
and 2 other patients had minimal change nephropathy. Two patients with
FSGS did not respond. Three of 4 patients with acute interstitial nephritis
were treated with acute hemodialysis and steroids. These 3 patients
recovered and the other patient also recovered without specific manage-
ment. With the above results, we thought that renal biopsy in the elderly
would be essential and helpful in various renal diseases, such as acute or
rapidly progressive renal failure and nephrotic syndrome.
Obstructive uropathy associated with systemic lupus erythematosus.
D.S. Moon, YS. Par/c, J.H. Son, M.J. Ahn, J.H. Lee, and H.J. Kim,
Department of Internal Medicine, College of Medicine, HanYang University,
Seoul, Korea. A patient with documented SLE is described who displayed
dysuria, gastrointestinal (GI) symptoms, and renal insufficiency associated
with the unusual occurrence of bilateral hydroureteronephrosis due to
stricture of ureterovesical junction (obstructive uropathy) on radiographic
findings. Pathologic investigations disclosed chronic interstitial cystitis(IC) with evidence of focal immune complex deposition in blood vessel
walls of the bladder. The GI symptoms and dysuria regressed with initial
therapy of SLE by steroids, but persistent obstructive uropathy (OU) and
renal insufficiency required bilateral nephrostomy. Following continuous
medical treatment with steroids plus intravenous pulse injections of
cyclophosphamide, the obstructive uropathy was relieved even with re-
moving the nephrostomy tube, and renal function remained stable.
Including this case, 19 patients who had SLE associated with clinical and
radiographic findings of OU were found in the world literature and
reviewed to find any consistent pattern of clinical features. Most of the
patients with OU in SLE were female (mean age 31.7 years) and orientals
(63%) and had interstitial cystitis (89%) as a common underlying cause
with concomitant involvement of GI tract (89%) and advanced glomeru-
lonephritis of WHO class IV or V (67%). Despite a remarkable response
to steroids in many patients (68%) of OU in SLE, certain patients still
required surgical correction (32%) and some even died (32%). OU,
potentially reversible, was not an exception in patients with SLE, which
might be overshadowed by other major organ involvement of SLE.
Clinical study on lupus nephritis. T.J. Choi, KS. Yoon, T W. Lee, C.G.
Ihm, and M.J. Kim, Department of Internal Medicine, Kyung Hee University,
School of Medicine, Seoul, Korea. We investigated the clinical manifesta-
tions, laboratory findings, and renal biopsy findings of 44 lupus nephritis
patients after admission to Kyung Hee University Medical Center from
March 1986 to February 1994, and the following results were obtained: (1)
male to female ratio was 1:13.6. The majority of patients were in the
second and third decades of life; (2) the incidence of American Rheuma-
tism Association criteria for SLE revealed that the hematologic disorder
was 94%, antinuclear antibody (ANA) was 89%, and immunologic
disorder 85%. Upon admission, the most common hematologic abnormal-
ity was anemia 93%; (3) The most common clinical feature was fever in
67%, gastrointestinal disorder in 31%, and hypertension in 28%. (4) In 33
cases, renal biopsy was performed and the most common histologic type
was diffuse proliferative lupus nephritis. (5) On admission, 7 cases showed
decreased renal function with serum creatinine more than 1.5 mg/dl, and
15 cases of urine proteinuria more than 3.5 g/day. (6) The incidence of
decreased C3 titer was 79% and C4 titer 86%. (7) Therapy was as follows:
in 16 cases steroid therapy, and in 27 cases steroid and cyclophosphamide
combination treatment. There was no significant treatment response in
both groups. (8) The causes of death in 14 patients with lupus nephritis
were reviewed. Renal failure, congestive heart failure, sepsis, pneumonia,
and cerebrovascular disease were noted.
Comparison of the patterns of hyperlipidemia in the idiopathic ne-
phrotic syndrome and secondary nephrotic syndrome caused by type II
DM. Hf. Noh, SW Lee, SW. Kang, KH. Choi, H.Y Lee, and D.S. Han,
Department of Internal Medicine, College of Medicine, Yonsei University,
Seou4 Korea. To investigate the patterns of hyperlipidemia in idiopathic
nephrotic syndrome and secondary nephrotic syndrome caused by type II
DM, we compared serum cholesterol, triglyceride, and HDL cholesterol
between them. In addition, we evaluated the correlation between serum
cholesterol and 24 hour urinary protein excretion, serum albumin, serum
total protein, and serum triglyceride. Nephrotic syndrome was defined as
24 hour urinary protein excretion more than 3.5 g and serum albumin
below 3.0 g/dl. All patients had normal renal (serum creatinine  1.5
mg/dl), hepatic, and thyroid function, and they did not take any medica-
tions that could affect the lipid profile. Forty-three were minimal change
nephrotic syndrome (MCNS) patients (Group I), 25 were non-MCNS (13
MGN, 5 FSGS, 3 MPGN, and 4 IgA nephropathy, Group II), and 19 were
patients with nephrotic syndrome caused by type II DM (Group III).
Serum creatinine in group III (1.2 0.3 mg/dl) was significantly higher as
compared to that in group 1(0.9 0.3 mg!dl) (P < 0.05) but did not differ
from that in group II (1.0 0.3 mg/dl), and serum albumin was
significantly lower in group 1(1.6 0.5 mgldl) than in group 11(2.1 0.6
mg/dl) and III (2.4 0.4 mg/dl) (P < 0.05). Serum cholesterol (499 123,
413 163, and 277 87 mg/dl in group I, II, and III, respectively) and
serum triglyceride (342 217, 362 260, and 243 186 mg/dl in group
I, II, and III, respectively) were elevated in all groups, and there was a
significant difference in serum cholesterol between each of the three
groups. But there was no difference in serum triglyceride, HDL choles-
terol, and cholesterol/HDL cholesterol ratio among them. Serum choles-
terol negatively correlated with serum albumin and serum protein in group
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I and II (P < 0.05), but in group III there was a significant negative
correlation only between serum cholesterol and serum protein (P < 0.05).
In group II, serum cholesterol correlated well with serum triglyceride and
24 hour urinary protein excretion. Cholesterol/24 hour urinary protein
excretion ratio (68.7 37.7, 54.6 24.8, and 43.0 25.5 in group I, II,
and III, respectively) was significantly elevated in group I compared to
group III (P < 0.05). By multivariate analysis, serum albumin in group I,
serum albumin and triglyceride in group II, and serum protein in group III
affected serum cholesterol independently. In conclusion, hyperlipidemia
in secondary nephrotic syndrome was milder than that in idiopathic
nephrotic syndrome, and there was no correlation between serum choles-
terol and 24-hour urinary protein excretion in secondary nephrotic
syndrome caused by type II DM. Therefore, there may be some different
pathophysiologic mechanisms in hyperlipidemia between idiopathic and
secondary nephrotic syndrome.
Interpretation of photon defect on DMSA renal scan in children with
urinary tract infection. J.S. Byun, S. W. Han, S.H. Lee, S.K. Cho4 and J.D.
Lee, Department of Urology and Nuclear Medicine, Yonsei University College
of Medicine, Seoul, Korea. In the detection of renal scars, dimercaptosuc-
cinic acid (DMSA) renal scan is used frequently, due to its convenience
and high sensitivity, but high false positive rates are its major drawbacks.
To improve accuracy and reproducibility of the DMSA renal scan, we
retrospectively analyzed DMSA scans of 45 children (29 male, 16 female,
mean age = 3.7 years) having upper urinary tract infections, which
presented the photon defect found at the initial DMSA scan, and at more
than three follow-up studies.
Photon defect
45 cases (68 kidneys)
Completely
resolved
Partially
resolved
Persisted or
aggravated
N of cases (kidneys)
Scan within 6 months 15 (18) 13 (21) 3 (5)
after upper UTI (31
cases)
Scan after 6 months 1(2) 3 (5) 10(17)
after upper UTI (14
cases)
With VUR (38 cases) 11(13) 15 (24) 12(20)
Without VUR (7 cases) 5 (7) 1(2) 1(2)
Total 16(20) 16(26)
35.6% (29.4%) 35.6% (38.2%) 2 13(22)8.9% (32.4%)
Of the photon defects found within six months after the attack of upper
urinary tract infection, 48% turned Out not to be an actual renal scar. The
photon defects without vesicoureteral refiux resolved more frequently
than the defects with vesicoureteral refiux. Some of photon defects were
seen to resolve, even 18 months after the initial scan, but no disappearance
of scars was observed after 18 months. Therefore it is thought that the high
false rate during this period would be diminished by other accompanying
tests, such as conventional urography or ultrasonography. The follow-up
study is necessary at least 18 months after an attack of upper urinary tract
infection. If a photon defect persists after this period, a renal scar can be
regarded as truly meaningful.
Clinical outcome of congenital urinary tract anomalies diagnosed by
prenatal ultrasonography. J.J. Park, P.-K. Kim, V. W. Park, Department of
Pediatrics, Sowha Children s Hospital, Departments of Pediatrics, Obstetrics
and Gynecology, Yonsei University College of Medicine, Seoul, Korea.
Prenatal ultrasonography (U/S) provides accurate detection and classifi-
cation of urinary tract anomalies which make up the majority of prenatal
anomalies. More than 90% of fetal anomalies can be detected at about 20
weeks of gestational age. Early diagnosis of urinary tract anomalies by
prenatal U/S may be able to prevent progression of renal damage. Also,
the majority of infant fetal urinary tract anomalies can be prevented by
allowing the immediate management of these infants after delivery. In this
study, infants with suspected urinary tract anomalies by prenatal U/S were
followed up with postnatal U/S, and a coorelative analysis was done
between pre- and post-natal U/S. Between January 1990 and June 1994, 39
infants with urinary tract anomalies were diagnosed by prenatal U/S and
were re-evaluated after delivery. Fifteen thousand and three hundred fifty
cases of prenatal U/S were performed. And among them, 39 cases (0.25%)
were diagnosed with urinary tract anomalies. Among them, 29 cases
(74.3%) had pelvic dilation, 9 cases (23.1%) had cystic diseases and I case
(2.6%) had renal mass. After delivery, follow-up studies revealed 18 cases
(46.2%) with ureteropelvic junction obstruction, 8 cases (20.5%) with
multicystic dysplastic kidney and 3 cases (7.7%) with vesicoureteric
junction obstruction. Seven cases (17.9%) had a normal kidney. Other
associated anomalies included the Turner syndrome, Dandy-Walker syn-
drome, hernia and congenital heart disease. Among the 29 cases with
pelvic dilatation, 22 cases had diameter greater than 10 mm and 7 cases
had between 5 and 9 mm. Postnatal U/S was normal for these renal
dilatation of diameter less than 10 mm. However, dilations greater than 10
mm were abnormal. We conclude that urinary tract anomalies comprise
0.25% of all prenatal U/S and when renal dilation, which has a diameter
greater than 10 mm, is discovered on prenatal U/S, postnatal follow-up
studies should be carried out.
Significance of fractional excretion of anions in differentiation of
metabolic acidosis. G.H. Kim, YY. Chung, C.H. Kim, U.S. Jeon, J.S. Han,
S. Kim, and J.S. Lee, Department of Intemal Medicine, Hallym University
and Seoul National University College of Medicine, Seoul, Korea. Tradition-
ally the serum anion gap (AG) has been used as a key ruler in the
differential diagnosis of metabolic acidosis. However, the same etiology
could present variable AG, and the classification based 'n the serum AG
may not be pathophysiologic. Recently, the fractional excretion of anions
(FEA) has been suggested as a tool to examine the renal handling of
anions, hut the significance is not revealed. To evaluate the significance of
FEA in the differentiation of metabolic acidosis, we measured FEA=
(UAO/SAG)/(UCr/SCr) X 100(%)J in 32 patients with metabolic acidosis,
who were grouped into those with acid overproduction (group I) and those
with indirect loss of bicarbonate due to low excretion of ammonium
(group II). Group I included 4 patients with diabetic ketoacidosis (DKA)
and 7 patients with lactic acidosis (LA), and group II included 4 patients
with distal renal tubular acidosis (dRTA) and 17 patients with chronic
renal failure (CRF). HCO1 (=24-HCO3) had no differences among
DKA (13.0 1.6 mM), LA (9.6 2.1 mM), dRTA (6.1 0.5 mM), and
CRF (10.2 0.8 mM). As compared with group I (DKA 98.6 19.6
mmol/day, LA 75.7 22.6 mmol/day), group II (dRTA 22.5 3.1
mmol/day, CRF 11.7 2.0 mmol/day) had a lower rate of ammonium
excretion (P < 0.01). As compared with group I (DKA 4.8 2.0%, LA 4.5
3.1%), group II (dRTA 16.9 6.9%, CRF 42.8 3.9%) had a higher
value of FEA (P < 0.01). FEA was inversely associated with urine
ammonium excretion (r = 0.63, P < 0.01). As compared with group I
(DKA 0.38 0.15, LA —0.05 0.52), group II (dRTA 2.62 0.98, CRF
4.57 0.44) had a higher value of FEA/LHCO (P < 0.01). We conclude
that metabolic acidosis caused by indirect loss of bicarbonate due to low
excretion of ammonium including dRTA and CRF had a higher value of
FEA as compared with that caused by acid overproduction including DKA
and LA, and the two groups could be more clearly differentiated by the
index of FEA/HCOI. Further studies to elucidate the mechanisms of
the difference in fractional excretion of anions are required.
Ovarian hyperstimulation syndrome (OHSS): A rare, but unique renal
dysfunction seeking for a nephrologic consultation. J.H. Kim, J.H. Bang,
TH. Kwon, YL. Kim, D.K. Cho, Department of Internal Medicine, Kyung-
pook University Hospital, Taegu, Korea. The ovarian hyperstimulation
syndrome is a serious complication produced after the use of gonado-
tropin-releasing hormone agonists and gonadotropins administered for
induction of ovulation. The hallmarks of this syndrome are ovarian
enlargement by multiple follicles and alterations in capillary hemodynam-
ics leading to fluid loss from the vascular space. In its most severe form,
OHSS can cause massive ascites and pleural effusions, acute renal failure,
coagulation abnormalities, hepatic failure, and adult respiratory distress
syndrome. We report 11 hospitalized cases who were consulted from the
infertility clinic due to severe OHSS among 200 cases treated by gonado-
tropins in Kyungpook University Hospital between January 1993 and
March 1995. We found that (1) all patients complained of nausea,
vomiting, abdominal pain and abdominal distension. (2) On admission, all
patients had ascites and bilateral ovarian enlargement by multiple follicles.
Five patients presented with a pleural fluid collection on chest X-ray, while
none had peripheral edema. (3) Each patient developed OHSS 8.00
5.87 (I to 21) days following human chorionic gonadotropin (hCG)
administration. (4) Laboratory data showed hemoglobin 13.40 1.73 g/dl,
hematocrit 41.08 4.87%, serum sodium 137.54 3.86 mmol/Iiter,
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potassium 4.50 0.55 mmol/liter, BUN 4.35 2.12 mmol/liter, and
creatinine 66.81 14.99 j.tmol/liter. Common features included decreased
serum albumin (2.74 0.44 g/dl), markedly increased plasma renin
activity (30.13 17.94 ng/ml/hr), and aldosterone level (1760.60 1190.67
pg/mI). (5) All patients were treated with conservative methods such as
bed rest and intravenous fluid infusion. Seven patients diagnosed with
complicating severe ascites were treated with plasma expander such as
albumin and/or plasmanate. No patients were given furosemide. In
summary, we report 11 cases with OHSS after hCG administration, all of
whom were treated by conservative methods. We suggest that further
understanding of renal dysfunction in OHSS in terms of low serum
albumin and high plasma renin activity is needed.
Renal functions in asymptomatic Korean adults (mass study). D.C. Jin,
YS. Yoon, and BK. Bang, Department of Internal Medicine, Catholic
University Medical College, Seoul, Korea. We analyzed renal function and
related factors (serum creatinine with BUN, proteinuria, blood pressure,
cholesterol, glucose, body mass index) in 50,000 asymptomatic Korean
adults with regular health check-up data during June 1990 to December
1994 in Kangnam St. Mary's Hospital, Seoul, Korea. Abnormal renal
function cases (serum creatinine 1.4 mg/dl or over) were 743 in 50,000
person (prevalence rate 1.49%).
Male (N = 31,633) Female (N = 18,367)
Serum creatinine
overall mg/dl 1.076 0.19 0.824 0.13
20—29 y/o mg/dl (N 1,204) 1.06 (N = 929) 0.82
30—39 y/o mg/dl (N = 7,051) 1.07 (N 4,383) 0.81
40—49 y/o mg/dl (N = 12,527) 1.08 (N = 6,465) 0.82
50—59 y/o mg/dl (N = 8,390) 1.08 (N = 4,799) 0.84
60—69 y/o mg/dl (N = 2,039) 1.08 (N 1,571) 0.85
70 and over mg/dl (N = 422) 1.12 (N = 220) 0.91
BUN mg/dl 14.7 5.0 12.5 4.2
Urine occult 3,695 (11.7) 5,329 (29.0)
blood (+) %
Proteinuria 4,011 (12.75) 1,853 (10.1)(+) %
BP mm Hg 125.7 18.6/79.1 11.8 124.0 21.3/76.6 11.9
BMI 23.51 2.63 23.02 2.94
Multiple regression analysis showed that BUN, proteinuria, serum cho-
lesterol, hematuria had weak correlation coefficient (P < 0.0001, R2
0.07).
Urinary mass screening in Korea. C.G. Lee, H.S. Lee, S.J. Suh,
Department of Pediatrics, In-fe University, Department of Pathology, Seoul
National University, and Seoul School Health Center, Seoul, Korea. In an
effort to detect renal diseases early, urinary mass screening has been
performed in Seoul since 1981. This study was designed to determine the
prevalence of asymptomatic proteinuria and incidence rates of incipient
renal diseases in school-aged population from the results of urinary mass
screening. From 1987 to 1994, over 8 years, one half million of students in
Seoul comprised of 3 different age groups (11, 14 and 17, respectively) had
been screened for proteinuria each year in 3 steps; the initial screening at
schools, the second at the school health center and the third at a hospital.
Proteinuria was defined as more than I + reaction on dipsticks. In the
third test, children who showed proteinuria in the first and second tests
were grouped into 5 categories according to the types of proteinuria
revealed: transient proteinuria (type 1), orthostatic proteinuria (type 2),
constant proteinuria (type 3), proteinuria and hematuria (type 4), and
transient proteinuria and hematuria (type 5). Although the first 2 types
were regarded as normal, extensive evaluations were done for the
remaining 3 types because they denote incipient renal diseases. Results
were as follows: (1) Overall annual prevalences of asymptomatic protein-
uria ranged 0.20—0.36% (mean 0.28%). The 14-year-old age group
showed a higher prevalence rate compared to those of 11, 17 age groups
(0.36% vs. 0.20, 0.25%). (2) No significant difference between male and
female in terms of prevalence rates of asymptomatic proteinuria appeared
(male 0.25%, female 0.29%). (3) Tn the third test, orthostatic proteinuria
was most common 55%, and transient proteinuria was found in 17%,
Therefore, 72% of children who showed proteinuria in the first and second
tests seemed to be normal. Constant proteinuria, proteinuria and hema-
tuna and transient proteinunia and hematuria were 6%, 20% and 2% of
the subjects, respectively. Therefore, 28% of children in the third test had
renal diseases. (4) The overall annual incidence rate of incipient renal
disease was 2.7 per 10,000 children. (5) Renal pathologic findings of 80
children who showed types 3, 4 or 5 proteinuria revealed a variety of
glomerulopathy: IgA nephropathy 38.9%, MPGN 10.0%, membranous
nephropathy 7.5%, reflux nephropathy 7.5%, FSGS 6.2%, epithelial
disease 6.2%, and mild focal glomerulonephritis 6.2%. The remaining
17.5% had lupus nephritis, PSAGN, Wilms tumor, Alport syndrome, renal
The and other. (6) HBV associated nephropathy comprised of 7.5%. (7)
The annual incidence rate of IgA nephropathy was 1.1 per 10,000 children.
(8) Ten children were confirmed to have CRF in the third test. Among
them, 4 had reflux nephropathy, and I patient each had FSGS, MPGN and
IgA nephropathy, respectively.
Relationship between atherosclerosis and endothelin in essential hy-
pertension. GB. Choi, M.J. Hong, D.H. Kang, KI. Yoon, Department of
Internal Medicine, College of Medicine, Ewha Womans University, Seoul,
Korea. In recent years there has been several reports that plasma
endothelin concentration is elevated in hypertension. But there is debate
on the role of endothelin in hypertension. To investigate the relationship
between atherosclerosis and endothelin in hypertension, we measured
carotid intima-media thickness by an B-mode ultrasonic system, serum
lipoprotein(a) by ELISA, and plasma endothelin by RIA. Twenty-six
patients with essential hypertension (male 8, female 18) were studied. We
measured the maximum intima plus media thickness. The morphologic
changes were regarded as positive sonographic finding if there was
atheroma or the intima-media thickness was greater than 1.3 mm. There
was significant correlation between plasma endothelin concentration and
serum lipoprotein(a) level (r = 0.57, P < 0.05). In 8 patients with elevated
serum lipoprotein(a) level (>20 mg/dl), plasma endothelio concentration
was significantly higher than in 18 patients with normal serum lipopro-
tein(a) level (3.1 1.44 vs. 2.4 0.68, P < 0.05, 1-tail prob.). No
significant difference in carotid intima-media thickness was found between
the above two groups. There were no significant differences in plasma
endothelin concentration or serum lipoprotein(a) level between patients
with positive and those with negative sonographic findings. These results
suggest that the elevated plasma level of endothelin in patients with
essential hypertension may be related to endothelial damage such as
atherosclerosis. However, this is hardly to say that the morphologic
changes on sonography may exactly reflect the local damage of endothe-
hum.
Lovastatin inhibits PDGF- and EGF.induced DNA synthesis and
proliferation of cultured rat glomerular mesangial and aortic smooth
muscle cells. SW. Kang, SW. Lee, KH. Choi, H.Y. Lee, D.S. Han, andB.S.
Kang, Department of Internal Medicine, Department of Physiology, College of
Medicine, Yonsei University, Seou4 Korea. We investigated the effect of
lovastatin on PDGF- and EGF-indueed DNA synthesis and proliferation
of cultured glomerular mesangial and aortie smooth muscle cells isolated
from Sprague-Dawley rats. In addition, exogenous mevalonate and cho-
lesterol were added with lovastatin to determine which metabolite played
a more important role in DNA synthesis and cell proliferation. PDGF
stimulated DNA synthesis and proliferation of cultured glomerular mes-
angial and aortic smooth muscle cells in a dose-dependent manner. At a
concentration of 10 ng/ml, PDGF caused a 544.5% increase in DNA
synthesis of cultured mesangial cells, and at 25 ng/ml, it caused a 434.5%
increase in DNA synthesis of cultured smooth muscle cells assessed by
3H-thymidine incorporation. EGF also stimulated DNA synthesis and at a
concentration of 100 ng/ml, it increased 3H-thymidine uptake of cultured
mesangial and smooth muscle cells by 519.5% and 390.6%, respectively.
The results of cell proliferation assessed by cell numbers paralleled the
results of 3H-thymidine incorporation. Lovastatin caused a dose-depen-
dent inhibition of PDGF- and EGF-induced DNA synthesis of both cells.
At the highest lovastatin concentration (10 zM), PDGF-indueed DNA
synthesis of mesangial and smooth muscle cells were reduced by 94.4%
and 84.5%, respectively. EGF-indueed DNA synthesis of mesangial cells
was also inhibited by 97.9%, and that of smooth muscle cells by 99.2% with
10 M lovastatin. The inhibitory effect of lovastatin on DNA synthesis and
proliferation was prevented by exogenous mevalonate but not by LDL-
cholesterol. In conclusion, lovastatin had an inhibitory effect on PDGF-
and EGF-induced DNA synthesis and proliferation of smooth muscle cells
708 Abstracts
as well as mesangial cells by a direct cellular effect. Moreover, it was likely
that some metabolites of mevalonate pathway rather than cholesterol
itself played an important role in growth regulation.
Elfects of insulin-like growth factor-I on two kidney vs. one kidney in
hypophysectomized rats. S. W. Han and S.K Choi, Department of Urology,
Yonsei University College of Medicine, Seoul, Korea. There is no evidence of
glomerulosclerosis following compensatory renal hypertrophy in the state
of growth hormone (GH) deficiency. flypertrophy without sclerosis might
be induced by GH non-dependent insulin like growth factor-I (TGF-I) in
the remaining kidney. Until now the role of IGF-I in absence of GH
during compensatory hypertrophy has not been elucidated. To investigate
the effects of external IGF-I on the short term renal function in absence
of GH, adult rats were treated with recombinant human IGF-I (rhIGF-I)
in two kidney and one kidney model. In hypophysectomized Sprague-
Dawley rats, sham-operated (two kidney model) and uninephrectoniized(one kidney model) rats were treated with 300 mg of rhIGF-I daily for 5
days, and subsequent weight wet of kidney, IGF-I concentration of renal
tissue by radioimmunoassay, and glomerular filtration rate (GFR) and
effective renal plasma flow (ERPF) per wet kidney weight by the recovery
rate of ssmTcDTPA and 1251-hippurate were evaluated. (1) The wet
kidney weight was increased after UNX and not significantly changed with
rhIGF-I treatment in both models. (2) After UNX the renal IGF-I tended
to increase, and GFR and ERPF increased (P < 0.05 and P < 0.001,
respectively). (3) rhIGF-I treatment increased GFR in both two (P <
0.001) and one kidney model (P < 0.01). (4) rhIGF-I treatment increased
ERPF in two kidney model (P < 0.01), but did not significantly change in
one kidney model. Despite of GH deficiency by hypophysectomy, UNX
increases the renal function. External rhIGF-I treatment increases ERPF
and GFR in two kidney model, and increases GFR without the change of
ERPF in one kidney model during compensatory hypertrophy. Therefore
IGF-I in absence of GH also increases the short-term renal function, thus
external administration of IGF-I during compensatory renal hypertrophy
could enhance GFR by inducing changes of efferent arteriole or glomer-
ular filtration fraction without effecting ERPF.
Effect of HMG CoA reductase inhibition on TGF-1 mRNA expression
in diabetic rat glomeruli. D.C. Han, J.H. Kim, M.K Cha, K!. Song, S.D.
Hwang and H.B. Lee, Hyonam Kidney Laboratory, Soon Chun Hyang
University, Seoul, Korea. Lovastatin has been shown to ameliorate albu-
minuria and glomerulosclerosis in diabetic rats. TGF-J3 has recently been
implicated in the pathogenesis of diabetic nephropathy. Thus increased
expression of TGF-13 transcripts and protein and/or specific matrix
proteins known to be induced by TGF-13 have been reported in the
glomeruli of diabetic animals and humans. Based on these observations,
we examined the effect of lovastatin on the glomerular expression of
TGF-/31 mRNA in streptozotocin-induced diabetic rats by non-isotopic in
situ hybridization utilizing digoxigenin-labeled RNA probe. In the normal
rats (N = 21), there was little or no expression of TGF-131 mRNA. In the
vehicle-treated rats (N = 32), a marked increase in the glomerular
expression of TGF-131 mRNA was observed from 2 to 14 days after
induction of diabetes. Glomerular TGF-J31 mRNA expression was signif-
icantly suppressed in lovastatin-treated rats (N = 32) 2 days after
induction of diabetes and was not different from that of normal rats. It
would appear from our observation and those of others that mevalonate
pathway is involved in the regulation of gene expression of several
cytokines and growth factors including TGF-p that are involved in cell
proliferation and matrix synthesis. Future studies are needed to elucidate
the mechanism of lovastatin-induced inhibition of TGF-13 mRNA in
diabetic kidney.
Chronic hypokalemia promotes differential expression of the "gastric"
H/K-ATPase a subunit gene in rat kidney. KY. Ahn, PB. Turner, KM.
Madsen, and B. C. Kone, Chonnam National University Medical School,
Kwangju, Korea, and University of Florida, Gainesville, Florida, USA.
Chronic potassium (K) restriction leads to active K reabsorption in the
late distal nephron and collecting duct, segments known to basally express
mRNA encoding the gastric H/K-ATPase a subunit. Moreover, functional
studies indicate that H/K-ATPase activity in these segments increases with
K deprivation, suggesting that this enzyme effects K conservation. To
determine whether expression of the gastric H/K-ATPase isoform is
regulated by changes in K balance, we assessed the cellular distribution
and relative abundance of mRNA encoding this isoform in kidneys of
normal and K-deprived (2 weeks) rats. The K-deprived rats developed
profound hypokalemia (serum [K} 2.6 0.2 mEq/liter vs. 5.2 0.2
mEq/liter for controls). In situ hybridization with isoform-specific cRNA
probes derived from the 5' (366-542) and 3' (3091-3337) ends of the
gastric H/K-ATPase a subunit eDNA demonstrated prominent expression
of this gene in the connecting segment (CNT), entire collecting duct, and
renal pelvic epithelium in both groups of rats. In the K-restricted rats,
hypertrophy of the outer medullary collecting duct inner stripe was
observed RT-PCR products of the gastric isoform (nts 527-1731) were
detected in cortex, outer and inner medulla of both groups. Semiquanti-
tative RT-PCR analysis of mRNA levels in the renal parenchymal zones,
revealed 5-fold greater levels of gastric H/K-ATPase a subunit mRNA
(normalized to levels of 13-actin mRNA) in the cortex, but comparable
levels in the outer and inner medulla of K-restricted rats compared to
controls. We conclude that chronic hypokalemia promotes differential
expression of the gastric H/K-ATPase a subunit gene among the renal
parenchymal zones. Our data suggest that expression of this gene is
adaptively increased in the CNT and cortical collecting duct of K-deprived
rats. Thus, the gastric H/K-ATPase is likely to be one of the isozymes
responsible for renal K conservation during chronic hypokalemia.
Renal involvement in amyloidosis. I. Joo, SB. Park, J. Suk, H.C. Kim,
Department of Internal Medicine, Keimyung University School of Medicine,
Taegu, Korea. Renal involvement is the most common clinical feature of
amyloidosis, affecting over one third of patients at initial clinical presen-
tation. We retrospectively evaluated the clinical features and clinical
courses of 20 patients with amyloidosis that had been confirmed by various
tissue biopsy. Twenty patients with amyloidosis consist of 9 male patients,
11 female patients. Age of patients ranged from 26 to 77 years old, with a
mean age of 54 years old. Classification of amyloidosis in 20 cases were 7
cases of primary and 13 cases of secondary amyloidosis. Underlying
diseases of secondary amyloidosis were mostly rheumatoid arthritis, 9
cases (45%). The initial clinical features were generalized edema in 7
patients (35%), pain on extremities in 5 (25%), fatigubility, and weakness.
The renal manifestations were nephrotic syndrome in 9 patients (45%),
azotemia in 9 patients (45%), and a symptomatic urinary abnormality in 2
patients (10%). The diagnosis was established by biopsy of kidney in 11
cases, rectum in 13, lung in 2 with positive results of abdominal fat
aspiration in 19 cases (95%). Renal size was normal or enlarged in 16
patients (80%) and contracted in 4 (20%). The mean of duration
follow-up was 26 months ranged 1—92 months, and median survival was 22
months. The major cause of death was due to congestive heart failure in
3 cases and renal failure 3 cases. These findings suggest that amyloidosis
should be suspected in patients with proteinuria or progressive azotemia
in older ages. Intensive studies including abdominal fat aspiration for
amyloidosis in asymptomatic at-risk patients should be done and appro-
priate therapy instituted at an early stage.
Effect of detlazacort on therapeutic efficacy and bone mineral density
(BMD) in children with minimal change nephrotic syndrome. B.H. Choe,
C. W Ko, and J.H. Koo, Department of Pediatrics, Kyungpook National
University, School of Medicine, Taegu, Korea. A prospective study was
conducted to see the effect of deflazacort on therapeutic efficacy and BMD
in children with minimal change nephrotic syndrome. Study population
consisted of 10 deflazacort (DFZ)-treated nephrotic children (aged 1.5 to
14.5 years) and 5 prednisolone (PDN)-treated nephrotic children. De-
flazacort (2 mg/kg) or prednisolone has been administered daily for the
first 4 weeks of treatment, then administered every other day and slowly
tapered off during following 3 to 6 months. Serum protein, albumin and
spot unine Ca/Cr ratio were measured before and 1 and 3 months after
initiation of treatment. To see osteoblastic activity, serum osteocalcin was
measured at the same intervals. Vertebral BMDs were measured before
and 3 months after initiation of treatment by computerized tomogram.
The following results were obtained. In all nephrotic children of both
groups, remission occurred. BMD (mg/cm3), in DFZ group, decreased
from 154.8 24.5 to 135.1 19.7 at 3 months after starting DFZ; in the
PDN group, it changed from 181.0 50.6 to 129.2 48.8. The decrement
of vertebral BMDs was less prominent in DFZ group than PDN group
(P = 0.06). In summary, compared to prednisolone, DFZ seems to have
almost identical therapeutic effect in the treatment of children with
minimal change nephrotic syndrome, and the decrement of BMD seems to
be less prominent in DFZ group than PDN group.
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Comparative study on the effect in bone metabolism and efficacy of the
therapy with prednisolone and deflazacort (Calcort) in childhood He-
phrotic syndrome. M.J. Kwon, P.-K Kim, Department of Pediatrics, Yonsei
University College of Medicine, Seoul, Korea. The rate of remission induc-
tion with initial steroid therapy in children with minimal change disease is
known to be above 90%, of which 40% is frequently relapsing type. In the
steroid dependent type, significant side effects occur during the course of
therapy, such as osteoporosis, growth retardation, obesity, Cushing syn-
drome and diabetes mellitus. By binding to steroid receptor, deflazacort
(Calcort), an oxazoline derivative of prednisolone, exhibits anti-inflamma-
tory and immune suppressive effects, but decreases the incidence of
osteoporosis by lesser effect on calcium homeostasis and osteoclast
activation. Thus the authors investigated 38 patients who need long-term
steroid therapy because of nephrotic syndrome to evaluate the efficacy,
safety, and effect of defiazacort on bone metabolism. The 38 patients were
divided into two groups with using the classic prednisolone and the new
drug, deflazacort. Besides the laboratory parameters to ensure the effect
of treatment of the nephrotic syndrome, measurements of the bone
densitometry, serum levels of cortisol, parathyroid hormone, and osteo-
calcin at 0 and 3 months of treatment were done. Between these two
drugs, there was no difference in the therapeutic effects on the nephrotic
syndrome. The bone loss in the prednisolone-treated group was signifi-
cantly higher than that of the deflazacort-treated group (bone mineral
density 0 month vs. 3 month, 0.582 0.127 vs. 0.599 0.113 g/cm2 in
deflazacort-treated group, 0.644 0.133 vs. 0.615 0.159 g/cm2 in
prednisolone-treated group). There was a more marked fall in osteocalcin
in the prednisolone-treated group (0 month vs. 3 month, 83.21 57.91 vs.
29.26 27.84 ng/ml) compared to deflazacort-treated group (0 month vs.
3 month, 57.08 51.97 vs. 40.62 34.53 nglml). No significant difference
was demonstrated between the two groups concerning serum PTH and
cortisol. Thus, the detrimental effect of long-term steroid treatment on the
bone may not be abolished, but it can be significantly reduced by using
deflazacort instead of prednisolone.
Lipoprotein(a) levels and fibrinolytic activity in patients with nephrotic
syndrome. S.Y. Hong, D.H. Yang, Department of Internal Medicine, Soon-
chunhyang Chunan Hospital, Chunan City, Korea. In the nephrotic syn-
drome, hyperlipidemia is a common finding and thrombosis is a major
complication. With this regard, if Lp(a) levels increase concomitantly to
LDL and/or VLDL in nephrotic syndrome, it may be considered to be a
thrombogenic factor. To probe this possibility, and to corroborate the
relationship between Lp(a) and fibrinolytic profiles, we measured the
Lp(a) levels in nephrotic syndrome (N = 43) and observed the relation
between the Lp(a) level and the t-PA activity, euglobulin fibrinolytic
activity and t-PA antigen. Lp(a) levels were significantly higher in the
nephrotic syndrome patients compared to the control group (P < 0.001).
Lp(a) levels showed a reverse correlation with t-PA activity (R = 0.627,
P = 0.0001), total fibrinolytic activity in euglobulin fraction (R = 0.458,P = 0.0001), and t-PA activity divided by the t-PA ag (R = 0.567, P
0.0001), but no correlation with t-PA ag. Our results suggest that Lp(a)
may be an important thrombogenic factor in the nephrotic syndrome.
tnsulin-like growth factor binding proteins (IGFBPs) in children with
nephrotic syndrome. D.-Y. Lee, S.K Par/c and J.-S. Kim, Department of
Pediatrics and Internal Medicine, Chonbuk National University Medical
Schoo4 Chonju, Korea. Growth failure appears to be a major problem for
nephrotic children who fail to respond to steroid therapy. In this study, the
serum IGFBP profile was evaluated by Western ligand blot (WLB) and
radioimmunoassay (RIA) in 22 patients with nephrotic syndrome. Serum
IGFBP-3 was decreased whereas IGFBP-2 and IGFBP-4 were increased
in most patients with nephrotic syndrome. The mean serum IGFBP-3 level
was 2123 531 ng/ml in active states and was increased to normal levels
(3593 407 ng/ml) in remission states. We also measured serum IGF-I by
RIA. Serum concentration of IGF-I was 67.4 23.2 ng/ml in active states
and was increased to 127.1 21.8 ng/ml in remission states, but was still
lower than control subjects, 180.4 15.8 ng/ml. IGF-1 and IGFBP-3 levels
were appeared to be not correlated with primary renal disease or the
amount of proteinuria. Of serum IGF-IGFBP complexes, 150 kDa com-
plexes were significantly decreased in nephrotic syndrome compared with
control subjects. In urine from nephrotic syndrome, 150 and 50 kDa
complexes were found, whereas both complexes didn't exist in the urines
from control subjects. We speculate that low serum IGF-I and IGFBP-3
would be partially due to the increased urinary losses of serum IGF-
IGFBP complexes, especially 150 kDa, and these changes may contribute
to growth failure in persistent nephrotic syndrome.
Treatment of idiopathic membranous glomerulonephritis. S.J. Bae, SE.
Kim, and KH. Kim, Department of Internal Medicine, College of Medicine,
Dong-A University, Pusan, Korea. In patients with adult-onset idiopathic
membranous glomerulonephritis (iMGN), the clinical courses are variable
and there is no consensus about the efficacy of treatment with either
steroid or immunosuppressive agents. To evaluate the effects of drug
therapy, a consecutive study of 29 patients with iMGN (male 15, female
14, mean age 36.8 14.9 years old) observed for at least 6 months (range
6 to 111 months, mean 24 16 months) were analyzed retrospectively to
estimate the effect of treatment with steroid or immunosuppressive agents.
The final results were: complete remission in 4 out of 29 (10%), partial
remission in 10 of 29 (34%), no response in 12 of 29 (41%) cases, and
spontaneous partial remission in 2 of 29 cases after at least 4 weeks after
discontinuation of drug therapy. Also, a case of spontaneous complete
remission was observed without any therapy. Responses to initial steroid
therapy (in 25 cases) were: no response in 17 out of 25 cases (69%), partial
remission in 4 of 25 cases (16%), and complete remission in 3 of 25 cases
(12%). Responses to combination therapy (steroid, chlorambucil) in 8
cases were: partial remission inS out of 8 cases (61%), complete remission
in 1 of 8 cases, spontaneous partial remission in 1 of 8 cases, and no
response in 1 case. No cases had deterioration in renal function and final
serum albumin levels were significantly increased (P < 0.01). In conclu-
sion, the response to drug medication in iMGN was variable, and the
results of this study suggest that combination therapy with steroid and
chiorambucil (remission rate 70%) was more effective than that with
steroid only (remission rate 30%), and that iMGN has relatively benign
clinical course.
Suppressive effect of calcitriol on intact PTH in chronic renal failure.
J. J'V Park, J. Y Do, K W. Yoon, Department of Internal Medicine, Yeungnam
University Hospital, Taegu, Korea. To assess the suppressive effect of
calcitriol treatment in secondary hyperparathyroidism of CRF, 16 hemo-
dialysis patients (11 males, 5 females, mean age 41.5 years) with baseline
concentrations of intact PTH more than 120 ng/ml were selected in this
study. A total of 2.0 pg of Rocaltrol was given p.o. and intact PTH, ionized
calcium, total calcium and phosphate were checked at 0, 6, 12, 24, 48, 72
hours (N = 15). Calcijex 2.0 pg was given iv. and the above were checked
at 0, 2, 4, 8, 24, 48, 72 hours (N = 9). Paired t-tests were employed for
statistical analyses. There were no significant changes of ionized calcium,
total calcium and phosphate during oral and iv. calcitriol, except a
significant increment of ionized calcium at 4 hour after iv. calcitriol. In the
oral group, the intact PTH level at 24 hours was 167 163 ng/ml (basal
312 245 ng/ml, P < 0.05, N = 14) and 48 hour level was 147 163 ng/ml
(basal 302 239 ng/ml, P < 0.05, N = 15). In i.v. group, the intact PTH
level at 8 hours was 68.6 SOng/mi (basal 202 154 ng/ml, P < 0.05, N =
6). Intact PTH levels at 24 hours and 48 hours were 78 69 ng/ml and 108
115 ng/ml (basal 279 194 ng/ml, P < 0.05, N 7). The intact PTH
level at 72 hours was 128.9 159 ng/ml (basal 206.9 150 ng/ml, P < 0.05,N = 6). In two patients whose PTH levels were not suppressed by oral
calcitriol, PTH was suppressed by i.v. calcitriol. In conclusion, iv. calcitriol
is more effective in suppressing PTH than oral calcitriol, and suppression
of PTH without increment of ionized calcium at the time of PTH
suppression means a direct inhibitory effect of calcitriol on parathyroid
glands.
Analysis of consulted patients for nephrology in a Korean hospital. J. R.
Koo, YS. Kim, H.K Kim, Department of Internal Medicine, Anam Hospital,
Korea University, Seoul, Korea. To investigate the clinical characteristics of
consulted patients for nephrology in Korea University Anam Hospital, we
analyzed by the department reporting on the patient, the major consulted
problem and renal diagnosis after consult based on 196 consulted patients
during the period of 1 year from April 1994 to March 1995. The mean age
of the patients was 54 17 years and the male to female ratio was 1.38 vs.
1. A total of 70 patients (36%) had been have underlying diseases which
could affect renal function such as diabetes mellitus (38 patients, 54%)
hypertension (16 patients, 23%). The major consulted problems were
azotemia (95 cases, 50%), asymptomatic urinary abnormalities such as
hematuria and proteinuria (32 cases, 17%), edema (19 cases, 10%), and
electrolyte disorders (14 cases, 7%). The renal diagnosis after consult were
prerenal azotemia (28 cases, 15%), diabetic nephropathy (20 cases, 15%),
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drug induced nephropathy (20 cases, 11%; NSAID, 8 cases; aminoglyco-
side, 5 cases; cisplatin, 2 cases; mitomycine, 2 cases; rifampin, 2 cases),
ischemic ARF (16 cases, 9%; of which 12 cases need dialysis), CRF (16
cases, 9%, of which 3 cases need dialysis). The number and diagnosis of
consulted patients in each department were as follows. The Urology
Department reported 22 cases, 11%, which comprised mostly obstructive
uropathy caused by renal stone and BPH and prerenal azotemia. Obstet-
rics and Gynecology Department cited 22 cases, 11%, mostly obstructive
uropathy caused by cervical cancer. The Orthopaedic Department had 18
cases, 8%, mostly mild azotemia during perioperative period of fracture
and NSAID nephrotoxity. Finally, the Cardiology Department had 16
cases, 8%, mostly hypertensive nephropathy. In case of dividing those
Departments as medical and surgical groups the prerenal azotemia and
ischemic ARF were more frequent in surgical group than medical group
(22 vs. 6, 12 vs. 4) and vice versa for CRF (2 vs. 14; P < 0.05). As a result
of above study, we conclude that prerenal azotemia/ischemic ARF in
surgical group, which could be prevented by careful management of
perioperative fluid electrolyte balance and diabetic nephropathy, were
major consulted problems for the Nephrology Department.
Comparative study of serotonin concentration in chronic renal failure
(CRF) patients. SN. Kim, D.H. Kong, G.B. Choi, and K.!. Yoon, Depart-
ment of Internal Medicine, College of Medicine, Ewha Womans University,
Seoul, Korea. Serotonin (5-flydroxytryptamine) is a vasoactive substance
implicated in platelet dysfunction, hypertension, ischemic heart disease,
and pruritus in renal failure patients. Although there were several reports
about serotonin concentration and possible association with hypertension
in CRF patients, no concordant data were available. The present study was
undertaken to investigate the whole blood (measured by high performance
liquid chromatography) and plasma serotonin (measured by enzyme
immunoassay) in 35 hemodialysis (HD) patients, 10 CAPD, 14 CRF
patients prior to dialysis, and 20 normal controls and also to know the
relationship between serotonin concentration and the presence of iseh-
ernie heart disease and pruritus in HD patients with changes of serotonin
during HD session. There was no significant correlation between serotonin
level and age, blood pressure, duration of dialysis and other biochemical
parameters in the CRF and control groups. Whole blood and plasma
serotonin concentration decreased significantly in HD patients.
Control CRF HD CAPD
N 20 14 35 10
P-Serotonin 151.4 44.8 127.5 40.3 57.5 22.ft' 133.6 25.7
ng/ml
WB-Serotonin 6.8 2.9 6.9 3.1 5.6 3.6a 6.3 5.7
p.g/dl
________________________
ap < 0.01 vs. control, CRF and CAPD groups
In the HD group, whole blood serotonin showed significant correlation
with the peripheral platelet count (r = 0.3295, P < 0.05). Plasma serotonin
increased significantly with the time of dialysis despite no significant
changes in whole blood serotonin during the dialysis session. Whole blood
serotonin in HD patients with ischemic heart disease increased signifi-
cantly compared to the patients without ischemic heart disease (7.1 3.4
vs. 4.9 2.3 j.g/dl, P < 0.05). There was no significant difference in
serotonin according to the presence of pruritus. In conclusion, serotonin
concentration in HD patients was lower than CRF and CAPD patients.
And an increased level of serotonin maybe related with the ischemic heart
disease. Further studies are needed to know the exact mechanism of
diminished serotonin level in HD patients and whether the HD process
itself stimulates the platelet serotonin release as a marker of bioincom-
patibility.
EWects of various diets and anti-hypertensive drugs on the progression
of early renal failure. KS. Kim, KH. Kim, S.Y. Kim, YJ. Kong and WI
Maeng, Departments of Pediatrics and Pathology, College of Medicine, and
Department of Feed and Nutritional Science, College of Animal Husbandry,
KonKuk University, Seoul, Korea. To evaluate whether or not protein
restriction or moderate sodium reduction had its own beneficial effect and
increased the efficiency of the anti-hypertensive drugs enalapril (E) and
nieardipine (N) on the progression of renal failure, we conducted an
experimental study using 5/6 nephrectomized (U) rats. Study I compared
the effects of E, N and no anti-hypertensive drugs (C) in U rats fed a diet
of 6% protein content. Study 11 compared the effects of E, N and C in U
rats fed a diet restricted to 0.25% Na. In study I, UC rats developed
progressive hypertension (140 8 mm Hg, 162 5 mm Hg, 171 5 mm
Hg and 184 11 mm Hg at 4, 8, 12 and 16 weeks.) which was controlled
by E or N, and proteinuria (74 15 mg/day at 16 weeks) which was
decreased by E (42 12 mg/day) or N (48 8 mg/day) (P < 0.05).
Mesangial expansion score and glomerular volumes did not increase
progressively after 12 weeks and were not different at 16 weeks among the
three groups. In study II, UC rats developed progressive hypertension
(138 1 mm Hg, 154 5 mm Hg, 155 6 mm Hg and 178 7 mm Hg
at 4, 8, 12 and 16 weeks) which was prevented by E or N, and proteinuria
(82 11 mg/day at 24 weeks) which was decreased by E (57 3 mg/day)
(P < 0.05) and not by N (78 11 mg/day) (P> 0.05). Rats were sacrificed
at 24 weeks and had evidence of less severe renal disease. Mesangial
expansion score and glomerular volumes at 24 weeks were not different
among the three groups. In conclusion, protein or moderate Na restriction
retarded the progression of renal lesion throughout the study. Combined
treatment with protein or moderate Na restriction and anti-hypertensive
drugs appeared to show synergistic effects to attenuate glomerular injury.
Impaired circadian rhythm of blood pressure in various stages of renal
failure. H.C. Song, E.J. Cho4 1.5. Park, S.f Ahn, D.C. Jin, S.Y Kim, WS.
Koo, and BK. Bang, Department of Internal Medicine, Catholic University
Medical College, Seoul, Korea. To examine the diurnal variation of blood
pressure in patients with various stages of renal failure, 24 hour ambula-
tory blood pressure (AMBP) measurements were obtained. The patients
were subdivided into 10 subjects with mild renal failure group B: serum
creatinine (Sr) < 3 mg/dl], 23 with moderate to severe renal failure
(group C: SCr> 3 mg/dl) and 24 as a control group (group A). The causes
of disease are nondiabetic, 10 with chronic glomerulonephritis, 8 with
chronic tubulointerstitial disease, and 14 with hypertensive nephropathy.
The values of Sr in groups A, B, C are 0.9 0.2 mg/dl, 2.3 0.4 mg/dl,
7.5 3.1 mg/dl, respectively, and these are significantly different (P <
0.05).
Group A Gm up B
D N D N
SBP
DBP mm Hg
BP load %
118.2 11.3
77.0 8.5
4.1
102.8 99a
68.5 6.7a
6.5
137.9 22.7
81.9 22.4
324h
133.6 25.2
80.6 22.0
26.0'
D
Group C
N
SBP
DBP mm Hg
BP load %
126.2 22.9
76.8 21.3
50.4'
125.5 21.6
78.0 17.0
36.0c
Mean so a P < 0.001 in D vs. N; h P < 0.001 in group A vs. B; P <
0.001 in group B vs. C. Abbreviations are: D, daytime (11 a.m.—6 p.m.); N,
nighttime (11 p.m.—6 am.); SBP, systolic blood pressure; DBP, diastolic
blond pressure. BP load: percentage of elevated daytime (SBP > 140,
DBP > 90 mm Hg) and nighttime (SBP> 120, DBP > 80 mm Hg) blood
pressure measurements in a 24 hour period.
Mean AMBP was significantly reduced at night in control, but not in both
groups of renal failure. Despite satisfactory control of blood pressure in
groups B and C, impaired nocturnal decline means that autonomic nerve
dysfunction appeared in mild renal failure. Increased BP load in groups B
and C, especially group C, suggests that end organ damages are more
prominent in subjects with severe renal failure.
The reversibility and the temporal changes of carbamylated hemoglo-
bin in renal failure. YS. Kim, H.I Chin, H.I Yoon, C. Ahn, J.S. Han, S.
Kim, iS. Lee, 1G. fang, and S.G. Shin, Department of Internal Medicine
and Pharmacology, College of Medicine, Seoul National University, Seoul,
Korea. We have reported that the carbamylated hemoglobin (CarHb),
which is generated from the reaction of cyanate and hemoglobin amino
groups, correlated with the time-averaged urea concentration in patients
with renal failure. Since the aspect of the changes in CarHb is not
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well-known, we measured Carllb as valine hydantoin per g hemoglobin
using the HPLC method to assess the reversibility and the temporal
changes of CarHb in patients with acute or chronic renal failure. Thirty-six
patients referred to Seoul National University Hospital for management
of ARF were enrolled into the study from 1994 to 1995. Forty-six patients
with CRF and 31 healthy persons were also enrolled. To assess the
reversibility of CarHb, 6 patients admitted to this hospital for renal
transplantation were evaluated. The serum creatinine of patients with
ARF was lower than that of patients with CRF [4.8 mg/dl (2.0—14.3) vs. 6.8
(2.0—25.3), (median, range); P < 0.051, but BUN was similar between
these two groups [66 mg/dl (16—159) vs. 66 (16—168); P> 0.05]. CarHb of
patients with ARF was lower than that of patients with CRF [53.2 pg
VH/g Hb (24.6—97.1) vs. 115.7 (34.6—286.5); P < 0.011, but higher than
that of normal persons [53.2 (24.6—97.1) vs. 36.6 (19.9—62.9); P < 0.051.
CarHb was decreased by 19.7% (12.3—35.6) in 6 transplanted patients by
2—3 weeks after operation, but the hemoglobin increment was 25%
(4.0—46.6) during the same period. This meant the total CarHb was not
changed significantly. In the 6 patients with hemorrhagic fever with renal
syndrome, CarHb tended to rise after the 10th day of illness, but it was not
statistically significant. In conclusion, CarHb concentration was increased
with the renal failure and this was more evident in the patients with CRF.
The carbamylation of hemoglobin was irreversible during the observed
period. The process of carbamylation tended to ongoing with the persis-
tence of ARF.
Pathologicoclinical correlation for the diagnosis of renal allografts
classified by the Banil' schema for acute rejection. YJ. Cho4 C. W. Yang,
S.H. Lee, YS. Yoon, B.K Kim, S.M Kim, B.K Bang, and SI. Shim,
Department of Clinical Pathology and Internal Medicine, Catholic University
Medical College, Seoul, Korea. The Banif schema was published in 1993 for
an accurate diagnosis of renal allograft rejection. In this schema, tubulitis
and intimal arteritis were regarded as the principal lesions indicative of
acute rejection (AR). We studied the correlation between pathologic
diagnoses with individual pathologic parameters by Banif schema and
clinical diagnosis with clinical variables. Eighty-nine biopsies satisfied
histologic inclusion criteria. Twenty-one biopsies were obtained from
normal patients (Sr < 1.3). Of them, 52% (11/21) were VMAR or AR. Of
54 biopsies from borderline patients (5Cr is more than 1.3 and
changed < 30% in 2 weeks), 26% (14/54) were AR. Of 14 biopsies from
AR patients (Se. is more than 1.3 and changed > 30% in 2 weeks), 86%
(12/14) were normal or VMAR. Among clinical variables such as serum
creatinine, serum cyclosporine A level, degree of incompatibility of human
leukocyte antigen and cytotoxicity, type of donor and number of trans-
plantation, only serum creatinine level (P 0.026) was correlated with
pathologic diagnosis. There was no correlation between pathologic pa-
rameters by Banif schema and clinical variables.
Pathologic
diagnosis
Clinical diagnosis Case
no.
Serum Cr
mg/dlNormal Borderline AR
Normal 10 (48) 7 (13) 2 (14) 19 (22) 1.4 0.4
VMAR 9 (43) 33 (61) 10 (72) 52(58) 2.2 1.3
AR 2(9) 14(26) 2(14) 18(20) 2.3 1.4
Total no. 21 54 14 89
Abbreviations are: AR, acute rejection; Cr, creatinine; VMAR, very
mild acute rejection.
In conclusion, there are some discrepancies between clinical diagnosis and
pathologic diagnosis, so it is very important to confirm pathologic diag-
nosis especially for the differentiation of VMAR from AR when AR is
suspected clinically.
Influence of cyclosporine on compensatory renal growth in uninephrec-
tomized rats. C. W. Yang, SR. Lee, YS. Kim, WS. Koo, E.J. Choi, BK.
Bang, Department of Internal Medicine, Catholic University Medical College,
Seou4 Korea. This study was designed to evaluate the influence of
cyclosporine A (C5A) on compensatory renal growth (CRG). CRG was
defined by contralateral kidney weight gain (KW index) and increase in
proliferating cell nuclear antigen (PCNA)-positive cell (PCNA index)
after uninephrectomy (UNx). The following two groups were studied: (1)
Control group (UNx rats treated vehicle, N = 42); (2) CsA group (UNx
rats treated with CsA: 50 mg/kg/day, N 42). Following UNx, the animals
were sacrificed at 0, 12, 24, 48, 72, 120 and 168 hours. The KW index
between two groups showed significant change according to time interval
(P 0.0015). Between the two groups, the KW index in CsA group was
lower than control group at 120 and 168 hours (P < 0.01). In the cortex,
PCNA index between two groups showed a significant change according to
the time interval (P = 0.0001). Between two groups, the PCNA index in
the CsA group was lower than control group at 12, 24, 48, 72, 120 and 168
hours (P < 0.01). In medulla and glomeruli, the PCNA index between the
two groups showed no significant changes. This finding demonstrates that
CsA suppresses CRG, and inhibition of cellular proliferation by CsA
occurs in tubular cells in the cortex.
Immunocytochemical assay for cytomegalovirus detection in peripheral
blood for renal transplanted patients in clinical practice: Preliminary
study. SR. Wie, H.C. Song, S.A. Yoon, S.H. Lee, C.W. Yang, YS. Kim, S.Y.
Kim, and B.K Bang, Department of Internal Medicine, Catholic University
Medical College, Seoul, Korea. Culture techniques and serology were used
as standards for documentation of active cytomegalovirus (CMV) infec-
tion. However, viral culture takes too much time to detect CMV infection
and CMV antibody titers may not be risen in immunocompromized
patients. Recently, a CMV antigenemia assay has been proven to be both
a sensitive and a rapid technique for the detection of CMV infection. This
assay is based on direct detection of the CMV protein pp65 in prepara-
tions of peripheral leukocyte blood fractions. We are performing a
prospective study using the antigenemia assay for rapid detection of CMV
viremia in kidney transplant patients. Of 84 blood specimens from 40
patients (35 kidney transplant recipients and 5 donors), twelve (14.3%)
were positive in the CMV antigenemia assay, whereas these specimens
showed negative 1gM anti-CMV antibodies. All six patients who were
positive in the CMV antigenemia assay had no evidences of clinical CMV
infection. In conclusion, the CMV antigenemia assay is a sensitive and
rapid method for early detection of CMV infection in patients undergoing
kidney transplantation.
Urologic complications after renal transplantation. .1. Y. Lee, H.K Chae,
KW. Kahng, Hf. Kim, C.H. Park, S.M Kim, CM. Kang, and H.C. Park,
Department of Internal Medicine, College of Medicine, Hanyang University,
Seoul, Korea. Although the incidence of urologic complications after renal
transplantation is now infrequent and lower than the past, these compli-
cations may cause renal functional impairment, graft loss, and even death.
We evaluated the incidence, type of urologic complication and factors that
may influence these complications in patients who had received renal
transplantation in Hanyang University Hospital since 1978. The total
number of patients was 269, male:female ratio was 2.6:1, and cases of
secondary renal transplantation cases were 11(4%). The number of living
related donors was 143, that of living unrelated donors was 87, and that of
cadavors was 6. The method of anastomosis of ureter and bladder was the
Modified Lich's method (extravesical ureteroneocystostomy). The total
incidence of urologic complications in our cases was 7.4% (20 cases/269).
There were 4 cases (1.5%) of acute ureterovesical obstruction, 5 cases
(1.9%) of urinary leakage, 4 cases of delayed ureteral obstruction/
stricture, 3 cases (1.1%) of urinary stone, 1 case of perirenal abscess, and
1 case of ureteroneocystostomy site hemorrhage. In the cases of acute
U-V obstruction, the male:female ratio was 1:1, the average age 45, and
the initial diagnosis time was mean 1.5 days after operation. Among the 4
cases, there were 3 living related donors. In the cases of urinary leakage,
the male:female ratio was 4:1, the average age was 45, and the diagnosis
time was variable, from first day to 2 months after operation. Among the
cases of delayed ureteral obstruction, the male:female ratio was 3:1, the
average age was 41.3, two were related donors, and two were unrelated
donors. In the cases of uretheral obstruction, all occured in male patients,
the initial diagnosis time was mean 20 days after the initial operation. We
could not find any possible factor that may affect the incidence of urologic
complications.
